<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<url>
<loc>http://www.npra.gov.my/index.php/directives-circulars</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/application-procedures-application-form-for-glp</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/npra-glp-compliance-programme-manual</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/list-of-glp-compliant-test-facilities-2</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/list-of-glp-compliant-test-facilities</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/bioequivalence-guidelines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/generic-product-list-for-be-studies</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/be-studies-centres</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/biowaivers</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/application-forms-and-checklist</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/cosmetic-main-page</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/cosmetics-guideline-annex-i-vii</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directives-cosmetic-products</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/circulars-cosmetic-products</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/frequently-asked-questions-faqs</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/regulation-basic</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/register-usb-token</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/token-java-configuration</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-classification-guideline</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/guideline-for-the-submission-of-product-samples-for-laboratory-testing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/maintenance-of-registration</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/general-conditions-for-registration-of-drug-products-under-the-control-of-drugs-and-cosmetics-regulations-1984</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/amendment-to-the-particulars-of-the-product</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/withdrawal-of-product-registration</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/change-of-manufacturing-site-cos-application</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/change-of-product-registration-holder-coh</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/user-manual-for-quest-module</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/data-exclusivity</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/internet-browser-configuration</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/online-payments/payment-using-personal-account-b2c</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/online-payments/payment-using-corporate-account-b2b</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/online-payments/payment-using-credit-card</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/announcements</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directives</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/circulars</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/appformscomplicense</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/guidelines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/guidelines-3</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/traditional-product-registration-process</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/part-i/product-validation</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/part-i/product-validation/product-name</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/prescription-main-page</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-registration-process</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/guideline-for-prescription-medicine</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directives-prescription-medicines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/circulars-generic-medicines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/application-forms</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/faq-generic-medicines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/template-guide-for-product-information-pi-for-generic-products</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-registration-process/step-1-pre-submission-of-application-preparation</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-registration-process/step-3-regulatory-outcome</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-registration-process/step-4-post-registration-process</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/docman</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/rimup-vlr-pplr-be</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/submission-main-page</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-validation-main</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/product-name</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/dosage-form</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/active-ingredient</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/excipient</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/excipient-2</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-a</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-b-product-formula</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-c-particular-of-packing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-d-label-mock-up-for-immediate-container-outer-carton-and-proposed-package-insert-pil</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-e-supplementary-documentation-and-particulars-of-product-owner-manufacturer-importer-and-other-manufacturer</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-p-product-information</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/section-s-active-pharmaceutical-ingredient-api-information-submission</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/health-professionals</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/contact-us/staff-directory/staff-directory-23</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/contact-us/staff-directory</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/contact-us/our-location</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/contact-us/website-feedback-form</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/vision-mission-and-objective</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/roles-and-functions</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/organisational-chart</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/clients-charter</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/npra-obligation</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/addons-list-6/current-year-service-level-achievements</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/recognition-international-membership/who-collaborating-centre</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/recognition-international-membership/pic-s</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/recognition-international-membership/oecd-glp-mad</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/recognition-international-membership/asean-committee</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/recognition-international-membership/npra-awards-recognition</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/drug-control-authority-dca/dca-members</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/drug-control-authority-dca/about-the-dca</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/drug-control-authority-dca/dca-news</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/malaysian-adverse-drug-reactions-advisory-committee-madrac/madrac-introduction</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/about/malaysian-adverse-drug-reactions-advisory-committee-madrac/madrac-members</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/health-professionals/safety-alerts</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/health-professionals/reporting-adr</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/health-professionals/product-complaints</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/reporting/reporting-side-effects-to-medicines-conserf-or-vaccines-aefi</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/information/products-search</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/information/consumer-medication-information-leaflets-rimup</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/information/vaccine-lot-release-lot-release-certificate</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/information/plasma-products-lot-release</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/information/online-public-engagement</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/safety-information/cancellation-of-registered-complementary-alternative-product</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/safety-information/cancellation-of-notified-cosmetic-products</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/safety-information/adulterated-poducts-unregistered</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/safety-information/vaccine-lot-release-notification-of-non-compliance</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumers/safety-information/plasma-products-notification-of-non-compliance</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/general-information/announcement</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/general-information/press-release</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/general-information/circulars</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/general-information/training-seminars</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/publication/newsletter-berita-ubat-ubatan</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/publication/newsletter-madrac-bulletin</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/publication/national-centre-for-adverse-drug-reaction-monitoring-annual-report</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/publication/reaksi-drug-safety-news</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/new-products-indication/new-products-approved-quest3</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/new-products-indication/new-prod-quest3</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/new-products-indication/new-products-approved-quest2</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/new-products-indication/additional-indications-approved</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/new-products-indication/new-chemical-entities</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-manufacturers</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-importers</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/quest-list-of-manufacturers-wholesalers-importers/quest-cosmetic-manufacturer-list</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/quest-list-of-manufacturers-wholesalers-importers/senarai-pengilang-veterinar-yang-telah-diperiksa-dan-memenuhi-keperluan-apb</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/archives/newsletter-madrac-bulletin-archives</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/archives/newsletter-berita-ubat-ubatan-archives</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/archives/additional-indications-approved-archives</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/archives/new-products-approved-quest2-arkib</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/information/archives/new-products-approved-quest3-arkib</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/staff-directory-2</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/contact-us</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/public-enquiry-complaints</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/privacy-policy</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/security-policy</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/archives</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/staff-access</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/sitemap</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/consumer-medication-information-leaflets-rimup</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/main-page</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/regulation-basics</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/compliance-and-licensing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/cosmetic-products</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/laboratory-quality-control</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/good-laboratory-practice-glp-compliance-monitoring-programme</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/bioequivalence-be</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/active-pharmaceutical-ingredients-api</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/drug-registration-guidance-documents-drgd-e-book</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/asean-guidance-documents</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/veterinary</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/helpdesk-enquiry-complaints</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/clinical-trial/clinical-trial-guidelines</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/clinical-trial/clinical-trial-application-forms</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/hikashop-menu-for-categories-listing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/hikashop-menu-for-products-listing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/hikashop-menu-for-user-control-panel</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/hikashop-menu-for-hikashop-registration</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/hikashop-menu-for-brands-listing</loc>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1679-check?Itemid=437</loc>
<lastmod>2018-09-26T18:02:14Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1619-appendix-14-guidelines-on-safety-data-requirements-for-complementary-medicine-products?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1624-frequently-asked-questions-faqs-about-good-manufacturing-practice-gmp?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1625-frequently-asked-questions-faqs-about-foreign-gmp-inspection-on-manufacturers-of-pharmaceutical-products-by-national-pharmaceutical-regulatory-agency-npra?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1630-faq-clinical-trial-monthly-susar-reporting?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1631-faq-clinical-trial?Itemid=437</loc>
<lastmod>2018-07-29T08:49:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1514-step-3-screening-3?Itemid=437</loc>
<lastmod>2018-09-25T18:55:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1513-step-3-screening-2?Itemid=437</loc>
<lastmod>2018-07-17T22:17:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1440-conditions-pertaining-to-patent?Itemid=437</loc>
<lastmod>2018-07-12T00:18:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1230-workflow-for-manual-registration-of-for-export-only-feo-products?Itemid=437</loc>
<lastmod>2017-11-07T23:48:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1182-new-products-indication?Itemid=437</loc>
<lastmod>2017-06-15T23:38:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1181-quest3-product-search?Itemid=437</loc>
<lastmod>2017-06-20T22:51:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1162-seranta-awam-atas-talian-online-public-engagement?Itemid=437</loc>
<lastmod>2017-04-26T23:55:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1156-good-distribution-practice-gdp?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1152-borang-kemaskini-laman-web-online-npra?Itemid=437</loc>
<lastmod>2017-03-30T23:19:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1124-npra-publications?Itemid=437</loc>
<lastmod>2017-02-05T22:53:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1103-thank-you-for-your-scubscription?Itemid=437</loc>
<lastmod>2016-12-13T19:05:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1098-pembatalan-produk-semulajadi-tradiosional-komsetik?Itemid=437</loc>
<lastmod>2018-02-12T01:04:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1097-report-an-adverse-event?Itemid=437</loc>
<lastmod>2016-12-05T23:46:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1089-borang-untuk-kakitangan-npra?Itemid=437</loc>
<lastmod>2017-04-02T16:57:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1076-popup-email?Itemid=437</loc>
<lastmod>2016-09-25T19:15:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1059-popup-rimup?Itemid=437</loc>
<lastmod>2016-08-18T22:51:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1024-quest3-announcement?Itemid=437</loc>
<lastmod>2016-05-26T19:41:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/1006-phone-directory?Itemid=437</loc>
<lastmod>2017-11-22T17:21:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/992-sebut-harga?Itemid=437</loc>
<lastmod>2016-04-18T19:56:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/988-capa?Itemid=437</loc>
<lastmod>2016-05-06T01:30:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/960-plasma-products-lot-notification-of-non-compliance?Itemid=437</loc>
<lastmod>2015-12-03T02:09:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/959-plasma-products-lot-release?Itemid=437</loc>
<lastmod>2015-12-09T20:57:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/955-vaccine-lot-notification-of-non-compliance?Itemid=437</loc>
<lastmod>2015-12-03T02:08:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/946-popup-special-announcement?Itemid=437</loc>
<lastmod>2018-04-04T20:23:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/948-c-security?Itemid=437</loc>
<lastmod>2015-12-16T17:29:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/925-lot-release-certificate?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/949-b-online-system?Itemid=437</loc>
<lastmod>2015-12-16T17:29:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/916-directive?Itemid=437</loc>
<lastmod>2015-08-10T19:26:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/915-circular?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/908-product-cancellation?Itemid=437</loc>
<lastmod>2015-08-07T00:14:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/906-safety-alert?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/900-a-digital-certificate?Itemid=437</loc>
<lastmod>2015-10-27T01:18:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/871-press-release-archieve?Itemid=437</loc>
<lastmod>2015-08-04T01:05:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/730-announcement-archive?Itemid=437</loc>
<lastmod>2015-08-10T00:13:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/707-npbc-annual-report-archive?Itemid=437</loc>
<lastmod>2016-01-03T18:16:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/694-faqs?Itemid=437</loc>
<lastmod>2017-11-08T00:32:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/688-reporting-healthcare-professional?Itemid=437</loc>
<lastmod>2017-12-20T17:36:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/687-quest-system?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/685-product-registration-cosmetic-notification?Itemid=437</loc>
<lastmod>2015-10-20T19:23:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/674-reporting-medicinal-problems?Itemid=437</loc>
<lastmod>2015-08-05T18:27:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/673-faq?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/670-disclaimer?Itemid=437</loc>
<lastmod>2016-07-24T19:38:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/647-list-of-manufacturers?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/642-laboratory-quality-control?Itemid=437</loc>
<lastmod>2018-02-13T19:41:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/640-product-recall-procedures?Itemid=437</loc>
<lastmod>2015-07-09T20:09:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/638-veterinary?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/637-location-map?Itemid=437</loc>
<lastmod>2015-07-27T01:43:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/636-feedback-form?Itemid=437</loc>
<lastmod>2017-01-31T19:11:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/635-cosmetic?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/634-vaccine-lot-release?Itemid=437</loc>
<lastmod>2015-12-03T23:55:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/631-bioequivalence-be?Itemid=437</loc>
<lastmod>2015-07-07T23:15:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/629-guidelines-central?Itemid=437</loc>
<lastmod>2018-03-27T23:10:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/626-quest-3-pharmacy?Itemid=437</loc>
<lastmod>2015-07-07T20:51:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/625-quest-3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/624-helpdesk?Itemid=437</loc>
<lastmod>2016-08-25T16:10:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/616-application-forms?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/614-circular-directive?Itemid=437</loc>
<lastmod>2015-07-07T06:06:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/604-quest-list-recycle?Itemid=437</loc>
<lastmod>2016-01-26T20:14:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/603-quest-list-of-manufacturers-wholesales-importers?Itemid=437</loc>
<lastmod>2016-06-08T19:57:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/602-good-laboratory-practice-glp-compliance-monitoring-programme?Itemid=437</loc>
<lastmod>2018-01-29T16:16:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/601-licensing-manufacturer-importer-and-wholesaler?Itemid=437</loc>
<lastmod>2018-01-03T19:19:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/599-good-manufacturing-practice-good-distribution-practice?Itemid=437</loc>
<lastmod>2017-10-04T19:56:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/594-regulatory-guidelines?Itemid=437</loc>
<lastmod>2015-07-03T00:38:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/582-drug-registration-guidance-document-drgd?Itemid=437</loc>
<lastmod>2015-07-09T20:57:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/572-useful-links?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/571-cancellation-of-notification-of-cosmetic-products?Itemid=437</loc>
<lastmod>2016-09-09T09:53:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/567-cancellation-of-traditional-products?Itemid=437</loc>
<lastmod>2018-02-12T01:03:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/2-uncategorised/551-test-artikel?Itemid=437</loc>
<lastmod>2015-08-26T20:24:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/1014-q2-products-manual-renewal?Itemid=437</loc>
<lastmod>2016-05-10T23:01:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/1027-quest-suspension-banner?Itemid=437</loc>
<lastmod>2016-06-01T00:31:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/930-reaksi-drug-safety-news-banner?Itemid=437</loc>
<lastmod>2016-08-17T00:33:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/943-reaksi-banner?Itemid=437</loc>
<lastmod>2016-05-19T00:18:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/922-closure-of-veterinary-products-registration?Itemid=437</loc>
<lastmod>2016-05-03T19:35:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/936-madrac-banner?Itemid=437</loc>
<lastmod>2016-03-06T15:48:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/934-quest2-service-interruption?Itemid=437</loc>
<lastmod>2016-04-27T20:00:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/945-quest-2-traditional-products-registration-suspension?Itemid=437</loc>
<lastmod>2016-04-11T22:15:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/929-quest-3-system?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/923-quest-2-system?Itemid=437</loc>
<lastmod>2015-10-12T18:22:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/932-quest-3-membership-application-shutdown?Itemid=437</loc>
<lastmod>2016-05-03T23:52:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/523-welcome-to-the-npcb-new-portal?Itemid=437</loc>
<lastmod>2015-10-12T18:15:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/23-slideshow/522-the-npcb?Itemid=437</loc>
<lastmod>2016-09-25T19:14:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/30-about-npcb/947-client-charter?Itemid=437</loc>
<lastmod>2015-09-06T23:41:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/30-about-npcb/692-research-project-collaboration?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/30-about-npcb/555-online-web-statistics-analytics-visitors-client-charter?Itemid=437</loc>
<lastmod>2016-05-12T17:39:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/31-drug-registration-guidance-document/564-procedure-for-change-of-product-registration-holder-is-under-review?Itemid=437</loc>
<lastmod>2015-07-02T18:15:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/31-drug-registration-guidance-document/558-drug-registration-guidance-document?Itemid=437</loc>
<lastmod>2015-07-13T23:10:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/33-healthcare-professional/598-useful-link?Itemid=437</loc>
<lastmod>2015-07-05T19:13:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/33-healthcare-professional/597-cutaneous-adverse-drug-reaction-adr-classification?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/33-healthcare-professional/595-adverse-drug-reaction?Itemid=437</loc>
<lastmod>2015-07-03T00:24:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/33-healthcare-professional/596-product-complaint?Itemid=437</loc>
<lastmod>2015-07-05T17:59:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1633-direktif-untuk-semua-produk-yang-mengandungi-iodinated-contrast-media-pengemaskinian-sisip-bungkusan-dengan-maklumat-keselamatan-berkaitan-severe-cutaneous-adverse-reactions-scars</loc>
<lastmod>2018-07-29T08:21:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1634-direktif-untuk-semua-produk-yang-mengandungi-saccharomyces-boulardii-pengemaskinian-label-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-risiko-fungaemia</loc>
<lastmod>2018-07-29T08:20:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1635-direktif-untuk-semua-produk-yang-mengandungi-azithromycin-clarithromycin-erythromycin-dan-roxithromycin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-severe-cutaneous-adverse-reactions-scars</loc>
<lastmod>2018-07-29T08:19:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1637-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-second-edition-september-2016-revised-july-2018</loc>
<lastmod>2018-07-18T17:40:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1638-garispanduan-pelaksanaan-rimup-edisi-ketiga-julai-2018</loc>
<lastmod>2018-07-18T16:24:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1640-direktif-untuk-semua-produk-yang-mengandungi-efavirenz-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-qtc-prolongation</loc>
<lastmod>2018-06-27T00:25:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1641-direktif-untuk-semua-produk-yang-mengandungi-doxycycline-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-jarisch-herxheimer-reaction</loc>
<lastmod>2018-06-27T00:18:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1642-direktif-permohonan-pendaftaran-semula-produk-yang-pernah-didaftarkan-secara-pendaftaran-hak-dan-produk-not-commercially-viable-medicine-ncvm</loc>
<lastmod>2018-06-27T00:19:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1643-direktif-untuk-semua-produk-yang-mengandungi-prednisone-dan-prednisolone-kecuali-persediaan-topikal-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-scleroderma-renal-crisis</loc>
<lastmod>2018-06-27T00:19:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1644-direktif-untuk-semua-produk-yang-mengandungi-acetazolamide-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-severe-cutaneous-adverse-reactions-scars</loc>
<lastmod>2018-06-27T00:07:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1269-direktif-untuk-semua-produk-yang-mengandungi-propofol-dan-sodium-valproate-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-interaksi-ubat</loc>
<lastmod>2018-07-17T00:27:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1268-direktif-untuk-semua-produk-yang-mengandungi-minocycline-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress</loc>
<lastmod>2018-02-27T18:34:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1655-larangan-penggunaan-nama-dan-atau-pembungkusan-yang-sama-atau-menyerupai-dengan-produk-kosmetik-yang-telah-dibatalkan-atas-isu-campurpalsu</loc>
<lastmod>2018-06-10T16:14:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1259-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-second-edition-september-2016-revised-january-2018</loc>
<lastmod>2018-02-02T00:09:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1257-direktif-untuk-semua-produk-yang-mengandungi-levetiracetam-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-acute-kidney-injury-rhabdomyolysis-blood-creatine-phosphokinase-increased-dan-encephalopathy</loc>
<lastmod>2018-01-24T17:28:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1256-direktif-untuk-semua-produk-yang-mengandungi-cobicistat-dan-kortikosteroid-kecuali-produk-untuk-kegunaan-luaran-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-interaksi-ubat</loc>
<lastmod>2018-01-24T17:35:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1254-direktif-untuk-semua-produk-yang-mengandungi-ambroxol-dan-bromhexine-pengemaskinian-label-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-amaran-kesan-advers-anafilaksis-dan-severe-cutaneous-adverse-reactions-scars</loc>
<lastmod>2018-01-24T17:33:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1243-direktif-untuk-semua-produk-yang-mengandungi-statin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-immune-mediated-necrotizing-myopathy-imnm</loc>
<lastmod>2017-12-12T16:36:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1242-direktif-untuk-semua-produk-yang-mengandungi-bahan-aktif-azithromycin-dan-erythromycin-kecuali-persediaan-topikal-eksternal-dan-ubat-untuk-kegunaan-mata-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-amaran-berkaitan-risiko-infantile-hypertrophic-pyloric-stenosis-ihps</loc>
<lastmod>2017-12-12T16:34:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1241-direktif-untuk-semua-produk-yang-mengandungi-opioid-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-risiko-kesan-advers-serotonin-syndrome-kesan-daripada-interaksi-dengan-serotonergic-drugs-dan-risiko-kesan-advers-adrenal-insufficiency-dan-androgen-deficiency-akibat-penggunaan-jangka-panjang</loc>
<lastmod>2017-12-12T16:31:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1237-direktif-pindaan-had-harian-pengambilan-menthol-dalam-persediaan-oral</loc>
<lastmod>2017-11-29T00:25:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1228-direktif-untuk-semua-produk-yang-mengandungi-metformin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-penggunaan-dalam-kalangan-pesakit-yang-mempunyai-moderately-reduced-kidney-function-dan-pengukuhan-amaran-lactic-acidosis</loc>
<lastmod>2017-10-18T19:28:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1227-direktif-untuk-semua-produk-yang-mengandungi-fluconazole-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-baharu-berkaitan-risiko-spontaneous-abortion-serta-memperkukuhkan-maklumat-keselamatan-berkaitan-multiple-congenital-abnormalities-dan-penggunaan-dalam-kalangan-ibu-menyusu</loc>
<lastmod>2017-10-18T19:31:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1226-direktif-untuk-semua-produk-yang-mengandungi-opioid-dan-benzodiazepin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-interaksi-ubat</loc>
<lastmod>2017-10-18T16:38:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1225-direktif-untuk-semua-produk-yang-mengandungi-aripiprazole-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-kesan-advers-pathological-gambling-dan-impulse-control-problems-ii-direktif-untuk-semua-produk-yang-mengandungi-opioid-dan-benzodiazepin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat</loc>
<lastmod>2017-10-18T16:26:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1219-direktif-berhubung-penggunaan-label-keselamatan-hologram-meditag-4</loc>
<lastmod>2017-10-15T17:53:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1218-direktif-untuk-semua-produk-yang-mengandungi-testosterone-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-kesan-advers-susulan-penyalahgunaan-dan-kebergantungan-ubat</loc>
<lastmod>2017-10-02T00:26:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1217-direktif-untuk-semua-produk-yang-mengandungi-metronidazole-kecuali-produk-untuk-kegunaan-luaran-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-amaran-berkaitan-risiko-hepatotoxicity-dalam-kalangan-pesakit-cockayne-syndrome</loc>
<lastmod>2017-10-04T00:35:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1216-direktif-untuk-semua-produk-yang-mengandungi-hyoscine-bentuk-dos-injeksi-sahaja-pengemaskinian-sisip-bungkusan-dengan-maklumat-keselamatan-berkaitan-risiko-kesan-advers-serius-pada-pesakit-jantung-dan-kardiovaskular</loc>
<lastmod>2017-10-02T00:26:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1206-direktif-untuk-semua-produk-yang-mengandungi-proton-pump-inhibitors-ppi-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-risiko-kesan-advers-akibat-penggunaan-jangka-panjang</loc>
<lastmod>2017-08-23T22:16:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1205-direktif-untuk-semua-produk-yang-mengandungi-proton-pump-inhibitors-ppi-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-elevated-circulating-levels-of-chromogranin-a-cga</loc>
<lastmod>2017-08-23T21:54:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1189-direktif-untuk-semua-produk-farmaseutikal-yang-mengandungi-loperamide-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-risiko-kesan-advers-pada-jantung-yang-serius-susulan-pengambilan-loperamide-melebihi-dos-yang-disyorkan-dan-isu-penyalahgunaan</loc>
<lastmod>2017-07-12T17:34:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1188-direktif-untuk-semua-produk-farmaseutikal-yang-mengandungi-etoricoxib-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-berkaitan-perubahan-dos-permulaan-bagi-rawatan-rheumatoid-arthritis-dan-ankylosing-spondylitis</loc>
<lastmod>2017-07-12T17:28:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1177-direktif-untuk-semua-produk-yang-mengandungi-warfarin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-interaksi-ubat</loc>
<lastmod>2017-05-28T23:16:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1176-direktif-untuk-semua-produk-kontraseptif-kecemasan-yang-mengandungi-levonorgestrel-dengan-maklumat-berkaitan-interaksi-antara-ubat-ubatan-yang-dikelaskan-sebagai-hepatic-enzyme-inducer-dan-keberkesanan-kontrasepsi</loc>
<lastmod>2017-05-28T23:16:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1175-direktif-untuk-semua-produk-yang-mengandungi-miconazole-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-interaksi-ubat</loc>
<lastmod>2017-05-28T23:11:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1174-direktif-untuk-semua-produk-inhalasi-kortikosteroid-yang-digunakan-untuk-rawatan-chronic-obstructive-pulmonary-disease-copd-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-tambahan-berkenaan-peningkatan-risiko-pneumonia</loc>
<lastmod>2017-05-28T23:10:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1173-direktif-untuk-semua-produk-farmaseutikal-yang-mengandungi-chlorhexidine-pengemaskinian-sisip-bungkusan-label-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-risiko-reaksi-hipersensitiviti</loc>
<lastmod>2017-05-28T23:09:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1172-direktif-untuk-pendaftaran-semula-bersyarat-bagi-produk-farmaseutikal-berdaftar-yang-masih-belum-memenuhi-keperluan-data-kajian-stabiliti-dalam-zon-iv-b</loc>
<lastmod>2017-05-28T23:08:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1171-direktif-untuk-menguatkuasakan-penggunaan-guidance-document-and-guidelines-for-registration-of-cell-and-gene-therapy-products-cgtps-december-2015-dan-good-tissue-practice-guideline-2nd-edition-december-2015</loc>
<lastmod>2017-05-28T23:07:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1150-direktif-penggunaan-drgd-second-edition-september-2016-revised-march-2017</loc>
<lastmod>2017-03-23T18:01:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1149-direktif-untuk-menguatkuasakan-penggunaan-guideline-for-registration-of-drug-medical-device-and-medical-device-drug-combination-products</loc>
<lastmod>2017-03-16T23:08:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1141-pengesahan-fasiliti-pengendalian-produk-rangkaian-sejuk-bagi-premis-mengimport-dan-pemborong-keluaran-berdaftar</loc>
<lastmod>2017-02-26T17:50:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1136-direktif-keperluan-sijil-analisa-produk-siap-certificate-of-analysis-coa-for-finished-product-semasa-permohonan-pendaftaran-baru-produk-semulajadi-dan-produk-suplemen-kesihatan-dengan-general-claims</loc>
<lastmod>2017-02-15T23:11:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1135-direktif-bagi-semua-produk-yang-mengandungi-interferon-alfa-dan-interferon-beta-dengan-maklumat-keselamatan-berkaitan-risiko-kesan-advers-pulmonary-arterial-hypertension-pah</loc>
<lastmod>2017-02-15T23:12:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1114-direktif-bagi-semua-produk-yang-mengandungi-olanzapine-dengan-maklumat-keselamatan-berkaitan-kesan-advers-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1113-direktif-mengenai-keperluan-sijil-amalan-perkilangan-baik-apb-untuk-produk-kajian-farmaseutikal-bagi-tujuan-permohonan-lesen-import-percubaan-klinikal-lipk</loc>
<lastmod>2016-12-26T16:04:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1064-direktif-untuk-penggunaan-drug-registration-guidance-document-second-edition-september-2016</loc>
<lastmod>2016-09-01T18:37:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1048-direktif-untuk-melaksanakan-malaysian-variation-guideline-for-natural-traditional-medicine-homeopathy-and-health-supplement-products-abridged-evaluation</loc>
<lastmod>2016-07-28T17:28:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1047-direktif-bagi-semua-produk-yang-mengandungi-bahan-aktif-minyak-cajeput-melaleuca-leucadendra-dalam-bentuk-dos-topikal-dengan-menambah-kenyataan-amaran-berkaitan-risiko-masalah-pernafasan-kesukaran-bernafas</loc>
<lastmod>2016-07-26T17:12:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1043-arahan-pengarah-kanan-perkhidmatan-farmasi-bil-11-tahun-2016-penerimaan-pengesahan-pematuhan-apb-bagi-tujuan-pendaftaran-semula-produk-farmaseutikal-berdaftar</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1040-keperluan-good-laboratory-practice-glp-bagi-kajian-keselamatan-bukan-klinikal-untuk-tujuan-pendaftaran-produk-new-chemical-entity-nce-biologik-dan-produk-herba-dengan-tuntutan-terapeutik-tinggi</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1037-direktif-untuk-penilaian-laporan-pemeriksaan-pusat-kajian-bioekuivalens-be-bagi-pendaftaran-produk</loc>
<lastmod>2016-06-28T23:04:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1036-direktif-untuk-perlaksanaan-plasma-products-lot-release-ke-atas-semua-produk-plasma-yang-berdaftar-di-malaysia</loc>
<lastmod>2016-06-28T22:58:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1023-direktif-untuk-semua-produk-yang-mengandungi-bisphosphonate-alendronate-clodronate-ibandronic-acid-pamidronate-risedronate-zoledronic-acid-pengemaskinian-sisip-bungkusan-dengan-risiko-kesan-advers-berkaitan-osteonecrosis-of-the-external-auditory-canal</loc>
<lastmod>2016-05-19T17:23:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/994-direktif-untuk-penilaian-laporan-pemeriksaan-pusat-kajian-bioekuivalens-be-bagi-pendaftaran-produk-dan-notifikasi-kajian-be</loc>
<lastmod>2016-03-24T18:45:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/993-direktif-untuk-semua-produk-yang-mengandungi-mycophenolate-mycophenolate-mofetil-dan-mycophenolic-acid-pengemaskinian-sisip-bungkusan-dengan-maklumat-keselamatan-berkaitan-risiko-kesan-teratogenik</loc>
<lastmod>2016-03-24T18:46:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/980-direktif-untuk-semua-produk-yang-mengandungi-azithromycin-formulasi-sistemik-pengemaskinian-sisip-bungkusan-dengan-maklumat-keselamatan-berkaitan-kesan-advers-qt-prolongation-dan-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress</loc>
<lastmod>2016-02-04T19:19:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/979-arahan-pengarah-kanan-perkhidmatan-farmasi-bilangan-1-tahun-2016-direktif-mengenai-keperluan-pemeriksaan-amalan-perkilangan-baik-apb-luar-negara-bagi-tujuan-pendaftaran-pendaftaran-semula-produk-farmaseutikal-berdaftar-dengan-pihak-berkuasa-kawalan-dadah</loc>
<lastmod>2016-02-01T17:06:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/940-direktif-untuk-semua-produk-yang-mengandungi-montelukast-pengemaskinian-sisip-bungkusan-dengan-maklumat-kesan-advers-berkaitan-thrombocytopenia</loc>
<lastmod>2015-11-24T16:27:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/939-direktif-untuk-semua-produk-yang-mengandungi-diclofenac-formulasi-sistemik-pengemaskinian-sisip-bungkusan-dengan-maklumat-keselamatan-berkaitan-kesan-advers-kardiovaskular</loc>
<lastmod>2015-12-07T16:30:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/669-pengemaskinian-garispanduan-pelaksanaan-risalah-maklumat-ubat-untuk-pengguna-rimup</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/668-direktif-penguatkuasaan-keperluan-kajian-bioekuivalens-be-bagi-produk-generik-dalam-bentuk-dos-oral-tablet-kapsul-yang-bersifat-effervescent-dispersible-orodispersible-sublingual-buccal-dan-chewable-yang-mengandungi-bahan-aktif-racun-berjadual</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/667-direktif-guideline-on-gmp-for-veterinary-premixes-january-2015</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/666-direktif-untuk-semua-produk-metoclopramide-memperketatkan-indikasi-dan-mengehadkan-dos-penggunaan-berikutan-risiko-kesan-advers-neurologik</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/665-direktif-untuk-pelaksanaan-vaccine-lot-release-ke-atas-semua-produk-vaksin-yang-berdaftar-di-malaysia</loc>
<lastmod>2016-05-23T18:53:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/664-keperluan-ahli-farmasi-berdaftar-sepenuh-masa-untuk-mengetuai-bahagian-pengeluaran-premis-pengilang-produk-farmaseutikal-radio-farmaseutikal-dan-veterinar-yang-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd-perlanjutan-tarikh-perlaksanaan</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/608-direktif-untuk-semua-produk-domperidone-bagi-mengehadkan-penggunaan-berikutan-risiko-kesan-advers-jantung</loc>
<lastmod>2015-07-09T19:16:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/607-direktif-untuk-produk-yang-mengandungi-paracetamol-termasuk-produk-kombinasi-pengemaskinian-label-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-amaran-berkaitan-kesan-advers-serius-pada-kulit</loc>
<lastmod>2015-08-25T18:28:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1082-direktif-bagi-semua-produk-yang-mengandungi-warfarin-dengan-risiko-kesan-advers-calciphylaxis</loc>
<lastmod>2016-10-12T16:42:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1083-direktif-bagi-semua-produk-yang-mengandungi-codeine-dengan-maklumat-keselamatan-berkaitan-risiko-kesan-advers-respiratory-depression</loc>
<lastmod>2016-10-12T16:37:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/1084-direktif-bagi-semua-produk-yang-mengandungi-sodium-valproate-bagi-memperkukuhkan-amaran-berkaitan-risiko-abnormal-pregnancy-outcomes</loc>
<lastmod>2016-10-12T16:49:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/100-directives-biologics/1510-direktif-untuk-melaksanakan-guidelines-on-conditional-registration-for-new-chemical-entities-and-biologics-2</loc>
<lastmod>2018-07-22T18:46:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/100-directives-biologics/1137-direktif-untuk-melaksanakan-malaysian-variation-guideline-for-biologics-mvgb</loc>
<lastmod>2018-07-22T18:47:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/101-directives-nce/1508-direktif-untuk-melaksanakan-guidelines-on-conditional-registration-for-new-chemical-entities-and-biologics</loc>
<lastmod>2018-07-16T23:34:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directives-cosmetic-products/1251-larangan-penggunaan-nama-dan-atau-pembungkusan-yang-sama-atau-menyerupai-dengan-produk-kosmetik-yang-telah-dibatalkan-atas-isu-campurpalsu</loc>
<lastmod>2018-09-12T20:25:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directives/1298-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftran-baru-pendaftaran-semula-produk-farmaseutiakl-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd</loc>
<lastmod>2018-07-16T20:17:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/directive-general/136-directives-feo/1274-direktif-kaji-semula-pendaftaran-produk-untuk-tujuan-eksport-sahaja-for-export-only-feo</loc>
<lastmod>2018-07-17T00:10:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/1051-quest3-system?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/1002-list-of-private-laboratories-complying-to-npcb-s-requirements-for-traditional-products-testing?Itemid=437</loc>
<lastmod>2016-04-10T17:50:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/705-pharmacovigilance-product-registration-holders?Itemid=437</loc>
<lastmod>2016-11-01T23:59:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/704-quest2-quest3-online-submission-system-faq?Itemid=437</loc>
<lastmod>2015-12-16T17:27:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/703-product-registration-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:29:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/702-active-pharmaceutical-ingredient-api-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:29:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/701-veterinary-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:31:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/700-good-laboratory-practice-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:30:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/699-clinical-trials-safety-reporting-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:30:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/698-gmp-gdp-faq?Itemid=437</loc>
<lastmod>2017-04-09T16:53:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/697-licensing-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:30:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/696-cosmetic-faq?Itemid=437</loc>
<lastmod>2015-07-24T00:41:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/695-reporting-by-consumers-faq?Itemid=437</loc>
<lastmod>2015-10-26T22:10:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/627-faq-quest-system?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/693-adr-reporting-by-healthcare-professionals?Itemid=437</loc>
<lastmod>2016-11-02T00:03:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/623-product-registration?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/622-active-pharmaceutical-ingredient-api?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/621-veterinary?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/620-cosmetic?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/619-glp?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/618-clinical-trials-safety-reporting?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/617-good-manufacturing-practice-good-distribution-practices?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/615-licensing?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/613-reporting-by-product-registration-holders?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/606-reporting-by-consumers?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/37-faq/605-reporting-for-healthcare-professionals?Itemid=437</loc>
<lastmod>2015-07-07T21:23:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1232-enable-export-button-using-google-chrome?Itemid=437</loc>
<lastmod>2017-11-08T19:08:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1160-4-easy-steps-for-online-payment-in-quest3-system?Itemid=437</loc>
<lastmod>2017-04-17T23:43:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1075-user-manual-for-membership-registration-q3-2?Itemid=437</loc>
<lastmod>2016-09-25T16:37:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1073-faq-quest3-usb-token-update?Itemid=437</loc>
<lastmod>2016-09-20T19:49:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1063-b2b-payment-online-transaction-flow-2?Itemid=437</loc>
<lastmod>2016-09-04T23:48:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/75-faq/faq-quest3/1052-online-payment-for-quest3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/38-quest/630-quest-annauncement?Itemid=437</loc>
<lastmod>2015-07-07T23:00:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/38-quest/628-quest-information?Itemid=437</loc>
<lastmod>2015-07-07T23:58:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1267-kenyataan-akhbar-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual-feb2018?Itemid=437</loc>
<lastmod>2018-02-25T22:31:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1656-press-release-jun-2018?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1258-kenyataan-akhbar-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1246-kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual-dis-17?Itemid=437</loc>
<lastmod>2017-12-25T18:53:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1224-enyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual2017?Itemid=437</loc>
<lastmod>2017-10-17T00:34:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1170-kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2017-05-28T18:01:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1159-kenyataan-akhbar-kpk-11-april-2017-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2017-04-11T17:04:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1131-kenyataan-akhbar-kpk-8-februari-2017-mesej-whatapps-tular-berkaitan-tablet-paracetamol-2?Itemid=437</loc>
<lastmod>2017-02-07T23:13:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1110-kenyataan-akhbar-kpk-16-disember-2016-amaran-kepada-orang-awam-berkenaan-pengambilan-produk-tidak-berdaftar-creative-health-resources-chr-creative-herbs-dan-creative-health-resources-chr-creative-nutrition?Itemid=437</loc>
<lastmod>2016-12-19T00:48:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1117-kenyataan-akhbar-kpk-5-januari-2017-panggil-balik-produk-ternolol-50-film-coated-tablet-mal19940057az-di-malaysia?Itemid=437</loc>
<lastmod>2017-01-12T15:53:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1109-kenyataan-akhbar-kpk-7-november-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-za-faran-2?Itemid=437</loc>
<lastmod>2017-02-01T17:50:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1072-kenyataan-akhbar-kpk-15-september-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-super-resdong-dan-mujarab-resdong-plus?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1021-kenyataan-akhbar-kpk-17-mei-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-hai-leng-hai-beh-herbal-itch-removing-capsule?Itemid=437</loc>
<lastmod>2016-05-17T16:38:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1005-kenyataan-akhbar-kpk-15-april-2016-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-dong-mai-tan-dan-seven-leave-ginsengs?Itemid=437</loc>
<lastmod>2016-04-19T19:09:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/991-kenyataan-akhbar-produk-tradisional-li-chung-pill-ubat-bebola-dikesan-mengandungi-alkaloid-bertoksik?Itemid=437</loc>
<lastmod>2016-03-23T16:35:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/990-kenyataan-akhbar-produk-tradisional-el-biozing-dikesan-mengandungi-racun-berjadual-dexamethasone?Itemid=437</loc>
<lastmod>2016-03-23T16:35:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/981-kenyataan-akhbar-kpk-20-feb-2016-isu-kapsul-dari-daun-betik-minyak-kelapa-dara-beberapa-herba-lain-yang-dihasilkan-oleh-pihak-universiti-teknologi-malaysia-sebagai-anti-denggi-anti-zika?Itemid=437</loc>
<lastmod>2016-02-22T17:43:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/977-kenyataan-akbar-kawalan-kosmetik-di-malaysia?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/976-satu-produk-kosmetik-yang-dibatalkan-notifikasi-atas-isu-campurpalsu?Itemid=437</loc>
<lastmod>2016-01-26T06:41:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/39-press-release-2016/1085-kenyataan-akhbar-ketua-pengarah-kesihatan-malaysia-produk-tradisional-aman-liquid-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2016-10-17T16:38:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1436-circular-prescription?Itemid=437</loc>
<lastmod>2018-07-11T21:44:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1636-pekeliling-bil-3-2018-makluman-berkenaan-status-kemaskini-bahan-bahan-dalam-annex-pada-guidelines-for-control-of-cosmetic-products-in-malaysia-26-julai-2018?Itemid=437</loc>
<lastmod>2018-07-29T08:04:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1263-makluman-berkenaan-status-kemaskini-bahan-bahan-dalam-annexes-pada-guidelines-for-control-of-cosmetic-products-in-malaysia-7-februari-2018?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1249-lanjutan-tarikh-pelaksanaan-pemakaian-guideline-for-regsitration-of-drug-medical-device-and-medical-device-drug-combination-products-2?Itemid=437</loc>
<lastmod>2018-01-14T16:29:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1213-pengecualian-bayaran-fi-bagi-fasiliti-kerajaan?Itemid=437</loc>
<lastmod>2017-10-01T18:41:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1208-pekeliling-mengenai-pelaksanaan-produk-persediaan-parenteral-yang-telah-dikelaskan-sebagai-racun-di-bawah-akta-racun-1952?Itemid=437</loc>
<lastmod>2017-08-27T23:05:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1200-pekeliling-kawalan-produk-persediaan-parenteral-sebagai-racun-di-bawah-akta-racun-1952?Itemid=437</loc>
<lastmod>2017-08-15T17:08:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1195-pendaftaran-bersyarat-bagi-produk-produk-dengan-sijil-apb-dari-ministry-of-economic-affairs-taiwan?Itemid=437</loc>
<lastmod>2017-07-26T19:53:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1186-pekeliling-untuk-memaklumkan-status-kemaskini-bahan-bahan-dalam-annexes-pada-guidelines-for-control-of-cosmetic-products-in-malaysia-4-july-2017?Itemid=437</loc>
<lastmod>2017-07-04T22:43:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1155-makluman-pelaksanaan-yuran-pemprosesan-permohonan-variasi-produk-pada-1-april-2017?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1144-pekeliling-untuk-memaklumkan-penerbitan-edisi-terkini-garis-panduan-kosmetik-iaitu-guideline-for-control-of-cosmetic-products-in-malaysia-1st-revision-february-2017-3-mac-2017?Itemid=437</loc>
<lastmod>2017-07-04T22:45:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1127-pekeliling-berkenaan-keperluan-untuk-mengemaskini-memuat-naik-label-produk-kosmetik-pada-sistem-quest3?Itemid=437</loc>
<lastmod>2017-02-07T20:07:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1126-pekeliling-tindakan-punitif-regulatori-ke-atas-syarikat-pemegang-notifikasi-kosmetik-yang-gagal-dihubungi-oleh-agensi-regulatori-farmasi-negara-npra?Itemid=437</loc>
<lastmod>2017-02-07T20:05:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1120-170131-cosmetic-circular?Itemid=437</loc>
<lastmod>2017-01-30T18:31:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1088-pekeliling-pendaftaran-semula-bersyarat-bagi-produk-generik-berdaftar-yang-masih-belum-memenuhi-keperluan-kajian-bioekuivalens-be-semasa-proses-pendaftaran-semula-dan-produk-generik-yang-telah-digantung-pendaftaran-kerana-penilaian-laporan-kajian-be-didapati-tidak-memuaskan?Itemid=437</loc>
<lastmod>2017-01-30T18:27:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1035-pendaftaran-semula-bersyarat-bagi-produk-generik-berdaftar-yang-mengandungi-bahan-aktif-racun-berjadual-dalam-bentuk-immediate-release-oral-solid-dosage-form-yang-belum-memenuhi-keperluan-kajian-bioekuivalens-be-semasa-pendaftaran-semula-produk-dan-produk?Itemid=437</loc>
<lastmod>2016-06-22T16:39:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1034-aktiviti-pengilangan-produk-berunsurkan-makhluk-perosak-dalam-fasiliti-pengilangan-kosmetik?Itemid=437</loc>
<lastmod>2016-06-20T20:00:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1026-pendaftaran-bersyarat-bagi-produk-farmaseutikal-tempatan-dalam-bentuk-dos-injeksi-dan-modified-release-yang-dibenarkan-untuk-memilih-option-2-bagi-keperluan-kajian-validasi-proses-semasa-permohonan-pendaftaran-produk-baru?Itemid=437</loc>
<lastmod>2016-06-01T00:22:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1025-lanjutan-tarikh-penguatkuasaan-untuk-memunuhi-keperluan-kajian-bioekuivalens-be-bagi-produk-generik-dalam-bentuk-dos-oral-tablet-kapsul-yang-bersifat-effervescent-dispersible-orodispersible-sublingual-buccal-dan-chewable-yang-mengandungi-bahan-aktif-racun?Itemid=437</loc>
<lastmod>2016-05-31T17:50:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1020-pindaan-pekeliling-prosedur-kelulusan-bersyarat-bagi-pertukaran-tapak-pengilangan-change-of-manufacturing-site-cos-bagi-produk-produk-tradisional-jenis-i-ii-iii-dan-v?Itemid=437</loc>
<lastmod>2016-05-16T18:54:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1019-pekeliling-tindakan-regulatori-terhadap-produk-semulajadi-dan-suplemen-kesihatan-yang-gagal-mengemukakan-dokumen-sokongan-bagi-permohonan-pertukaran-tapak-pengilang-change-of-manufacturing-site-cos?Itemid=437</loc>
<lastmod>2016-05-16T18:53:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1010-pekeliling-untuk-memaklumkan-larangan-penggunaan-3-benzylidene-camphor?Itemid=437</loc>
<lastmod>2016-04-28T22:52:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/987-had-maksimum-bagi-yuran-pemprosesan-dan-pemeriksaan-pusat-kajian-bioekuivalens-be-tempatan-dan-yuran-pemeriksaan-amalan-makmal-baik-good-laboratory-practice-ke-atas-fasiliti-bukan-klinikal-di-malaysia?Itemid=437</loc>
<lastmod>2016-03-15T15:55:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/996-pekeliling-untuk-mekalumkan-pengilang-kosmetik-tempatan-berkenaan-keperluan-pematuhan-kepada-amalan-perkilangan-baik-apb-sebelum-mengemukakan-notifikasi-kosmetik?Itemid=437</loc>
<lastmod>2016-04-27T15:53:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/985-dasar-penguatkuasaan-regulatori-terhadap-produk-cell-gene-therapy?Itemid=437</loc>
<lastmod>2017-05-28T23:49:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/972-pekeliling-tindakan-punitif-regulatori-ke-atas-syarikat-pemegang-notifikasi-kosmetik-yang-gagal-dihubungi-oleh-biro-pengawalan-farmaseutikal-kebangsaan-bpfk?Itemid=437</loc>
<lastmod>2016-02-01T17:05:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/968-makluman-pelaksanaan-yuran-bagi-perkhidmatan-yang-dijalankan-oleh-biro-pengawalan-farmaseutikal-kebangsaan-bpfk-kementerian-kesihatan-malaysia-kkm-tahun-2016?Itemid=437</loc>
<lastmod>2016-02-01T17:06:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/964-pekeliling-penggunaan-nama-generik-pada-nama-produk-bagi-produk-farmaseutikal?Itemid=437</loc>
<lastmod>2015-12-20T20:00:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/954-pekeliling-untuk-memaklumkan-status-kemaskini-bahan-bahan-dalam-annexes-pada-guidelines-for-control-of-cosmetic-products-in-malaysia?Itemid=437</loc>
<lastmod>2015-11-26T23:08:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/963-pekeliling-tarikh-kuatkuasa-keperluan-baru-option-2-validasi-proses-untuk-permohonan-baru-produk-farmaseutikal-dan-permohonan-variasi?Itemid=437</loc>
<lastmod>2015-12-16T17:04:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/663-kawalan-produk-mengandungi-bahan-aktif-yang-mempunyai-berberine-secara-semulajadi?Itemid=437</loc>
<lastmod>2015-07-09T18:31:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/662-pekeliling-pemansuhan-sistem-rayuan-pengujian-sampel-appeal-for-sample-retesting-bagi-sampel-pendaftaran-produk-tradisional-yang-tidak-lulus-pengujian?Itemid=437</loc>
<lastmod>2015-07-09T18:31:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/661-pertukaran-sistem-pendaftaran-produk-daripada-quest-3-kepada-quest-2-bagi-kategori-produk-tradisional-versi-2-0?Itemid=437</loc>
<lastmod>2015-07-09T18:32:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/660-larangan-penggunaan-ubi-gadong-dioscorea-hispida-dalam-produk-ubat-yang-diambil-secara-oral?Itemid=437</loc>
<lastmod>2015-07-09T18:32:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/659-prosedur-kelulusan-bersyarat-bagi-pertukaran-tapak-pengilangan-change-of-manufacturing-site-cos-bagi-produk-produk-tradisional-bagi-jenis-i-ii-iii-dan-v-sahaja?Itemid=437</loc>
<lastmod>2015-07-09T18:32:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/658-pekeliling-larangan-penggunaan-nama-produk-yang-memberikan-imej-tradisional-untuk-produk-farmaseutikal-bukan-racun-berjadual-yang-mengandungi-bahan-aktif-sintetik-dalam-bentuk-sediaan-oral?Itemid=437</loc>
<lastmod>2015-07-09T18:46:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/657-pekeliling-permohonan-pendaftaran-semula-produk-quest-3-melalui-prosedu-manual?Itemid=437</loc>
<lastmod>2015-07-09T18:33:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1077-makluman-pelaksanaan-yuran-aktiviti-plasma-product-lot-release-yang-dijalankan-oleh-agensi-regulatori-farmasi-negara-npra-kementerian-kesihatan-malaysia-kkm?Itemid=437</loc>
<lastmod>2016-10-06T05:39:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/40-circulars/1079-lanjutan-tempoh-masa-untuk-meletakkan-huruf-z-pada-nombor-pendaftaran-ubat-ubatan-berkadar-sifar?Itemid=437</loc>
<lastmod>2016-10-06T05:43:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/circulars-cosmetic-products/1593-pekeliling-bil-3-2018-makluman-berkenaan-status-kemaskini-bahan-bahan-dalam-annex-pada-guidelines-for-control-of-cosmetic-products-in-malaysia</loc>
<lastmod>2018-09-12T19:32:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/176-circulars/circulars-general/1483-pekeliling-kriteria-baru-pengkelasan-produk-food-drug-interphase-fdi?Itemid=437</loc>
<lastmod>2018-07-26T17:01:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/732-delima-raja-urat-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/731-kosmetik-jenama-as-beauty-dan-golden-horse-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/727-jingzhi-yinqiao-jiedu-tablet-260-mg-pembatalan-pendaftaran-produk-tradisional-atas-sebab-campur-palsu?Itemid=437</loc>
<lastmod>2015-07-31T00:02:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/722-figure-up-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/718-collagen-slim-dan-beautiful-slim-body-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2015-07-30T23:29:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/709-kosmetik-dnars-magic-gold-foundation-dan-yellow-cream-krim-ku-neng-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2016-02-22T18:29:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/715-kosmetik-jenama-dermaceutic-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/711-majun-burung-unta-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2015-07-30T22:55:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/710-skyline-al-taqwa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2016-04-26T22:17:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/41-press-release-2014/708-kosmetik-sf-protect-perfect-day-cream-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2015-08-02T22:32:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/765-ulasan-kepada-laporan-dalam-china-press-1-februari-2013-bertajuk-france-banned-the-sale-of-oral-contraceptive-pills-which-caused-4-deaths?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/763-ulasan-kepada-laporan-dalam-china-sin-chew-daily-27-februari-2013-3-unregistered-health-supplement-product-suspected-from-malaysia-indonesia?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/761-empat-produk-kosmetik-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/759-press-release-by-dg-of-health-cancellation-of-registration-of-traditional-product-sta-lions?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/758-ulasan-kepada-artikel-dalam-sin-chew-daily-bertajuk-yin-ni-whitener-repair-cream-contains-high-level-of-mercury-hong-kong-health-dept-urged-consumers-not-to-use-it?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/757-joint-press-release-moh-malaysia-standards-malaysia-the-acceptance-of-malaysia-as-non-oecd-member-adhering-to-the-mad-in-the-assessment-of-chemicals-on-glp?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/755-kosmetik-jenama-cellnex-natural-99-dan-sf-beauty-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/754-ulasan-kepada-kenyataan-akhbar-berita-harian-bertajuk-nasihat-usah-guna-produk-kosmetik-tabita?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/752-ulasan-kepada-laporan-akhbar-china-press-bertajuk-tong-ren-tang-jian-ti-wu-bu-wan-contains-high-level-of-mercury?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/750-tiga-produk-kosmetik-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/748-kenyataan-akhbar-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-maajun-kuat-khasiat-sakit-pinggang?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/747-ulasan-kepada-kenyataan-akhbar-melecur-disapu-krim-kurus-sinar-harian-14-jun-2013?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/745-ulasan-kepada-laporan-dalam-kenyataan-akhbat-sin-chew-daily-bertarikh-10-julai-2013-bertajuk-2-whitening-products-contain-mercury-the-authority-of-singapore-urged-the-public-not-to-use-them?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/743-ulasan-kepada-laporan-dalam-surat-khabar-harian-metro-31-mei-2013-bertajuk-ubat-tahan-sakit-boleh-menyebabkan-serangan-jantung?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/742-ulasan-kepada-laporan-akhbar-the-star-bertarikh-9-september-2013-bertajuk-unlicensed-lipstick-may-contain-lead?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/740-ulasan-kepada-laporan-dalam-surat-khabar-nanyang-siang-pau-bertarikh-24-ogos-2013-bertajuk-is-niu-huang-jie-du-pian-poisonous-tong-ren-tang-the-standard-of-drug-usage-policy-for-western-medications-is-different-from-chinese-traditional-medications?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/739-figure-up-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/738-majun-taufiq-dua-istimewa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/737-majun-dua-istimewa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/736-madu-adunan-herba-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-madu-adunan-herba?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/735-oxyelite-pro-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/734-cosa-grande-platinum-capsule-350mg-dan-vita-essence-capsule-pembatalan-pendaftaran-produk-tradisional-atas-sebab-campur-palsu?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/42-press-release-2013/733-kosmetik-sensual-meiji-skin-renewer-cream-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/778-press-statement-pao-ni-kang?Itemid=437</loc>
<lastmod>2015-08-02T22:34:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/777-press-statement-produk-kosmetik-yang-dikesan-mengandungi-merkuri?Itemid=437</loc>
<lastmod>2015-08-02T22:34:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/775-press-reviews-quban-shuang-products-mercury?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/772-press-release-mymen-plus-capsule-400mg-cancelled?Itemid=437</loc>
<lastmod>2015-08-02T22:35:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/771-press-release-jin-fei-cao-san-extract-powder-sheng-chang-cancelled?Itemid=437</loc>
<lastmod>2015-08-02T22:36:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/769-press-release-list-of-cosmetic-products-containing-scheduled-poison?Itemid=437</loc>
<lastmod>2015-08-02T22:36:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/45-press-release-2012/768-press-release-consumers-cautioned-against-using-cosmetic-product-containing-scheduled-poison?Itemid=437</loc>
<lastmod>2015-08-02T22:36:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/794-ulasan-kepada-laporan-dalam-akhbar-kosmo-8-mac-2011-ancaman-syampu-guna-bahan-pencuci-lantai?Itemid=437</loc>
<lastmod>2015-08-02T23:33:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/792-kenyataan-akhbar-bagi-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2015-08-02T23:33:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/789-kenyataan-akhbar-pengguna-dinasihatkan-untuk-mengelakkan-dari-mengguna-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2015-08-02T23:32:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/788-press-statement-of-cosmetic-products-which-have-been-found-to-contain-scheduled-poison-derma-rx-arbutin-r-cream?Itemid=437</loc>
<lastmod>2015-08-02T23:32:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/786-review-for-a-press-statement-regarding-johnson-s-baby-shampoo-products?Itemid=437</loc>
<lastmod>2015-11-30T17:53:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/47-press-release-2011/785-traditional-product-twee-hong-suah-recalled?Itemid=437</loc>
<lastmod>2015-08-02T23:30:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/824-penggantungan-produk-sibutramine-oleh-european-medicine-agnecy-ema?Itemid=437</loc>
<lastmod>2015-08-03T19:01:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/823-amaran-kepada-pemegang-pendaftaran-pengilang-yang-membuat-perubahan-pada-ubat-berdaftar-tanpa-mendapat-kelulusan-dan-didapati-menjejaskan-mutu-dan-keberkesanan-ubat-tersebut?Itemid=437</loc>
<lastmod>2015-08-03T19:01:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/820-pindaan-pada-kenyataan-amaran-berkaitan-dengan?Itemid=437</loc>
<lastmod>2015-08-03T19:00:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/819-kenyataan-akhbar-larangan-penggunaan-produk-yang-dinotifikasikan-sebagai-produk-kosmetik-tetapi-diiklan-dan-digunakan-untuk-tujuan-merawat-perubatan?Itemid=437</loc>
<lastmod>2015-08-03T18:59:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/817-untuk-sebaran-serta-merta-oleh-pihak-berkuasa-kawalan-dadah-pbkd-kementerian-kesihatan-malaysia-panggilbalik-sukarela-produk-hydroxycut-di-malaysia?Itemid=437</loc>
<lastmod>2015-08-03T18:59:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/815-penjualan-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2015-08-03T18:58:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/813-status-keselamatan-terkini-bagi-ubat-rawatan-penyakit-diabetes-avandia-rosiglitazone?Itemid=437</loc>
<lastmod>2015-08-03T18:58:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/812-kenyataan-akhbar-pengguna-dinasihatkan-mengelak-dari-mengguna-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2015-08-03T18:57:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/811-kenyataan-akhbar-oleh-ketua-pengarah-kesihatan-ke-arah-perkhidmatan-farmasi-yang-cemerlang?Itemid=437</loc>
<lastmod>2015-08-03T18:57:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/810-panggilbalik-produk-po-chai-pills-oleh-health-sciences-authority-hsa-singapura-dan-department-of-health-hong-kong?Itemid=437</loc>
<lastmod>2015-08-03T18:56:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/809-kehadiran-fragmen-dna-porcine-circovirus-1-pvc-1-di-dalam-vaksin-human-rotavirus-hrv-rotarix?Itemid=437</loc>
<lastmod>2015-08-03T18:55:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/808-status-keselamatan-produk-berdaftar-poh-chai-pill?Itemid=437</loc>
<lastmod>2015-08-03T18:54:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/805-kenyataan-akhbar-keselamatan-produk-minyak-ikan?Itemid=437</loc>
<lastmod>2015-08-03T18:53:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/804-kenyataan-akhbar-pengguna-dinasihatkan-untuk-mengelakkan-dari-mengguna-produk-produk-kosmetik-yang-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2015-08-03T18:52:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/803-jingzhi-keshou-tanchuan-pill-registered-in-malaysia-is-safe-for-consumption?Itemid=437</loc>
<lastmod>2015-08-03T18:50:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/801-kenyataan-akhbar-penjualan-produk-tidak-berdaftar-357-nasal-spray?Itemid=437</loc>
<lastmod>2015-08-03T18:50:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/800-kenyataan-akhbar-penjualan-produk-tidak-berdaftar-amberine-capsule?Itemid=437</loc>
<lastmod>2015-08-03T18:49:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/796-kenyataan-akhbar-produk-tradisional-po-chai-pills-yang-disyaki-tiruan-di-campur-palsu-dengan-diclofenac?Itemid=437</loc>
<lastmod>2015-08-03T18:48:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/793-press-release-on-animal-testing-and-compliance-to-good-laboratory-practice-glp-of-organisation-for-economic-co-operation-and-development-oecd?Itemid=437</loc>
<lastmod>2015-08-03T18:47:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/791-kenyataan-amaran-berbentuk?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/787-maklumbalas-akhbar-mylotarg-for-leukemia-from-pfizer-resulted-in-high-mortality-rate-the-united-states-banned-its-sale-in-the-market?Itemid=437</loc>
<lastmod>2015-08-03T18:47:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/783-kenyataan-akhbar-laporan-oleh-hong-kong-consumer-council-berkenaan-produk-pewarna-kuku-yang-dikesan-mengandungi-bahan-kimia-toksik?Itemid=437</loc>
<lastmod>2015-08-03T18:46:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/782-status-keselamatan-terkini-bagi-ubat-rawatan-penyakit-diabetes-avandia-rosiglitazone-avandamet-kombinasi-rosiglitazone-metformin-dan-avandaryl-kombinasi-rosiglitazone-glimipride?Itemid=437</loc>
<lastmod>2015-08-03T18:45:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/779-kenyataan-akhbar-penggantungan-pendaftaran-produk-produk-yang-mengandungi-sibutramine-atas-sebab-keselamatan?Itemid=437</loc>
<lastmod>2015-08-03T18:45:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/776-kenyataan-akhbar-tarikbalik-dua-produk-pengilat-kuku-jenama-skin-food-yang-dikesan-mengandungi-benzene-oleh-health-sciences-authority-hsa-singapore?Itemid=437</loc>
<lastmod>2015-08-03T18:44:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/46-press-release-2010/774-keperluan-kajian-bioekuivalens-be-bagi-semua-produk-generik?Itemid=437</loc>
<lastmod>2015-08-03T18:42:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/821-maklumat-keselamatan-mengenai-produk-antimokrobial-sistemik-kumpulan-fluoroquinolones?Itemid=437</loc>
<lastmod>2015-08-03T17:22:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/818-maklumbalas-kepada-keratan-akhbar-sin-chew-daily-the-popular-non-prescription-drug-from-us-and-uk-alli-weight-loss-capsule-may-cause-damage-to-liver?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/816-kenyataan-amaran-berkaitan-dengan-potential-for-an-increase-in-risk-of-suicidal-thoughts-or-behaviours-yang-perlu-dimuatkan-pada-sisip-bungkusan-produk-antiepileptik?Itemid=437</loc>
<lastmod>2015-08-03T17:22:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/814-kenyataan-amaran-berkaitan-dengan-possible-interaction-between-clopidogrel-and-proton-pump-inhibitors-yang-perlu-dimuatkan-pada-sisip-bungkusan-produk-clopidogrel?Itemid=437</loc>
<lastmod>2015-08-03T17:22:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/807-kenyataan-amaran-berkaitan-dengan-potential-for-an-increase-in-risk-of-hepatotoxicity-yang-perlu-dimuatkan-pada-sisip-bungkusan-produk-propylthiouracil?Itemid=437</loc>
<lastmod>2015-08-03T17:23:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/802-kenyataan-amaran-berkaitan-dengan-severe-drug-interaction-between-colchicine-and-p-glycoprotein-or-strong-cyp3a4-inhibitors-yang-perlu-dimuatkan-pada-sisip-bungkusan-produk-colchicine?Itemid=437</loc>
<lastmod>2015-08-03T17:23:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/48-press-release-2009/799-kenyataan-amaran-berkaitan-dengan-increased-risk-for-opportunistic-infections-such-as-activation-of-latent-viral-infections-including-bk-virus-associated-nephropathy-yang-perlu-dimuatkan-pada-sisip-bungkusan-produk-immunosuppressant?Itemid=437</loc>
<lastmod>2015-08-03T17:23:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/49-press-release-2008/832-amaran-dari-u-s-food-drug-administration-usfda-berkaitan-penggunaan-ubat-untuk-rawatan?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/49-press-release-2008/831-larangan-penggunaan-bahan-pewarna-dalam-produk-mengandungi-bahan-aktif-prednisolone-dalam-bentuk-oral-solid?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/49-press-release-2008/829-metoclopramide-maklumat-keselamatan-mengenai-penggunaan-pada-kanak-kanak?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/49-press-release-2008/828-maklumat-keselamatan-produk-champix-varenicline-berkaitan-kesan-advers?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/50-press-release-2007/840-new-safety-concerns-relating-to-use-of-zelmac?Itemid=437</loc>
<lastmod>2015-08-03T18:40:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/50-press-release-2007/839-larangan-penggunaan-bahan-premix-dalam-formulasi-produk-semulajadi-tradisional?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/50-press-release-2007/838-drug-control-authority-statement-on-cardiac-safety-of-rosiglitazone-avandia?Itemid=437</loc>
<lastmod>2015-08-03T18:40:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/50-press-release-2007/837-suspension-of-products-containing-nimesulide?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/50-press-release-2007/834-products-containing-nimesulide?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/851-products-with-promethazine-hydrochloride?Itemid=437</loc>
<lastmod>2015-08-03T18:38:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/850-registration-of-products-with-gatifloxacin?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/848-products-containing-black-cohosh-related-to-serious-hepatic-reactions?Itemid=437</loc>
<lastmod>2015-08-03T18:38:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/847-kintop-capsule?Itemid=437</loc>
<lastmod>2015-08-03T18:38:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/845-health-supplements-containing-arginine?Itemid=437</loc>
<lastmod>2015-08-03T18:38:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/844-products-containing-ace-inhibitors?Itemid=437</loc>
<lastmod>2015-08-03T18:38:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/843-qmax-kapsul-350-mg?Itemid=437</loc>
<lastmod>2015-08-03T18:39:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/51-press-release-2006/842-labelling-as-derived-from-seafood?Itemid=437</loc>
<lastmod>2015-08-03T18:39:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/876-penutupan-menu-market-sampling-untuk-pengguna-pengguna-quest3-yang-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/875-senarai-pengilang-veterinar-yang-telah-diperiksa-dan-memenuhi-keperluan-apb-minima?Itemid=437</loc>
<lastmod>2015-08-04T00:16:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/874-borang-permohonan-pelan-aliran-premis-pengilang-baru-tambahan?Itemid=437</loc>
<lastmod>2015-08-05T18:56:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/873-invitation-to-the-intersessional-meeting-of-the-accsq-tmhs-pwg-and-tfrf-meeting-11-15-march-2013-myanmar?Itemid=437</loc>
<lastmod>2015-08-05T18:55:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/872-seminar-on-vetting-of-medicines-advertisement?Itemid=437</loc>
<lastmod>2015-08-05T19:10:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/870-panduan-pelaporan-aduan-produk-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-dan-pelaporan-kesan-advers-adr?Itemid=437</loc>
<lastmod>2015-08-05T18:54:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/869-pelaksanaan-keperluan-sistem-air-terawat-dan-pengudaraan-berpusat-di-premis-pengilang-tradisional?Itemid=437</loc>
<lastmod>2015-08-05T18:59:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/868-communicate-with-our-director-general-dg-of-health-malaysia-on-facebook?Itemid=437</loc>
<lastmod>2015-08-05T18:59:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/867-pembaharuan-notifikasi-kosmetik?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/866-advertising-program-for-national-regulatory-conference-2013-extended-until-6th-april-2013?Itemid=437</loc>
<lastmod>2015-08-05T18:57:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/865-presentation-slide-for-training-course-on-malaysian-variation-guideline-mvg-for-pharmaceutical-industry-9-10-april-2013-hotel-singgahsana-petaling-jaya-selangor?Itemid=437</loc>
<lastmod>2015-08-05T18:44:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/864-national-regulatory-conference-2013-registration-is-closed?Itemid=437</loc>
<lastmod>2015-08-05T18:42:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/863-slides-for-national-regulatory-conference-2013?Itemid=437</loc>
<lastmod>2015-08-05T18:41:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/862-borang-permohonan-pemeriksaan-amalan-perkilangan-baik-apb-bukan-rutin-bagi-pengilang-tradisional-dan-kosmetik?Itemid=437</loc>
<lastmod>2015-08-05T18:37:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/861-pembayaran-caj-pemeriksaan-amalan-perkilangan-baik-apb-yang-dijalankan-oleh-bpfk-ke-atas-pengilang-tradisional-kosmetik-secara-pra-bayar?Itemid=437</loc>
<lastmod>2015-08-05T18:37:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/860-19th-meeting-of-traditional-medicines-health-supplement-product-working-group-tmhs-pwg-related-meetings-24-26-june-2013-myanmar?Itemid=437</loc>
<lastmod>2015-08-05T18:36:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/859-20th-asean-thms-scientific-commitee-meeting-atsc-and-the-13th-task-force-meeting-on-asean-regulatory-framework-for-tmhs-tfrf-from-26th-30th-august-2013-in-bangkok-thailand?Itemid=437</loc>
<lastmod>2015-08-05T18:35:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/858-kenyataan-tawaran-sebutharga?Itemid=437</loc>
<lastmod>2015-08-05T18:33:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/857-carta-aliran-pemprosesan-permohonan-variasi-bagi-produk-quest-3-manual?Itemid=437</loc>
<lastmod>2015-08-05T18:32:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/856-hari-bersama-pelanggan-biro-pengawalan-farmaseutikal-kebangsaan-bpfk-2013?Itemid=437</loc>
<lastmod>2018-09-27T16:47:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/855-ulasan-kepada-laporan-dalam-kenyataan-akhbar-utusan-malaysia-bertarikh-19-september-2013-pengawet-memberi-kesan-alahan?Itemid=437</loc>
<lastmod>2015-08-05T18:30:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/854-tawaran-sebutharga-kerja-kerja-menaiktaraf-infrastruktur-dan-pendawaian-kantin-di-blok-b-biro-pengawalan-farmaseutikal-kebangsaan?Itemid=437</loc>
<lastmod>2015-08-05T18:30:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/853-tawaran-sebutharga-kerja-kerja-menaiktaraf-tandas-awam-di-hadapan-pusat-komplian-dan-perlesenan-pkp-blok-b-biro-pengawalan-farmaseutikal-kebangsaan?Itemid=437</loc>
<lastmod>2015-08-05T18:28:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/852-tawaran-sebutharga-kerja-kerja-menaiktaraf-tingkat-2-pusat-kawalan-kualiti-blok-c1-biro-pengawalan-farmaseutikal-kebangsaan-kkm?Itemid=437</loc>
<lastmod>2015-08-05T18:27:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/849-20th-meeting-of-the-asean-consultative-commitee-for-standards-and-quality-traditional-medicines-and-health-supplements-product-working-group-accsq-thhspwg-11-16-november-2013-yongyakarta?Itemid=437</loc>
<lastmod>2015-08-05T18:21:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/846-tawaran-sebutharga-kerja-kerja-menaiktaraf-lif-di-bangunan-blok-a2-biro-pengawalan-farmaseutikal-kebangsaan-kementerian-kesihatan-malaysia?Itemid=437</loc>
<lastmod>2015-08-05T18:20:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/841-bengkel-sehari-bersama-hempedu-bumi-penerapan-kawalan-kualiti-dalam-bahan-mentah?Itemid=437</loc>
<lastmod>2015-08-05T18:17:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/836-new-products-approved-quest-3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/44-announcement-2013/770-list-of-updates-on-gdp-guideline-2nd-edition-2013?Itemid=437</loc>
<lastmod>2015-08-05T18:12:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/830-cosmetic-seminar-organized-by-ctfa-in-collaboration-with-bpfk?Itemid=437</loc>
<lastmod>2015-08-05T18:03:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/827-invitation-to-the-22nd-meeting-of-the-asean-tmhs-scientific-committee-atsc-and-its-related-meetings-of-the-accsq-tmhs-pwg-task-forces-from-3-7-march-2014-kuala-lumpur-initial-announcement?Itemid=437</loc>
<lastmod>2015-08-05T18:01:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/826-quest-3-system-closure-on-10-16-february-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/825-final-call-for-cosmetic-seminar-2014-register-now-limited-seats-left?Itemid=437</loc>
<lastmod>2015-08-05T18:00:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/822-current-regulatory-system-in-oic-member-states-survey-form?Itemid=437</loc>
<lastmod>2015-08-05T17:58:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/806-kenyataan-tawaran-sebut-harga-bagi-pembekalan-consumable-items-dan-bahan-reagen?Itemid=437</loc>
<lastmod>2015-08-05T17:53:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/798-21st-asean-consultative-committee-for-standards-and-quality-pharmaceutical-product-working-group-meeting-first-announcement-further-information-will-be-provided-shortly?Itemid=437</loc>
<lastmod>2015-08-05T17:50:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/797-malaysian-variation-guideline-for-tm-hs-draft-1-3-and-presentation-slides-for-training-course-on-malaysian-variation-guideline-for-traditional-medicine-and-health-supplement-products?Itemid=437</loc>
<lastmod>2015-08-05T17:49:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/795-permohonan-pengiktirafan-makmal-swasta-oleh-bpfk-bagi-perkhidmatan-analisis-produk-tradisional?Itemid=437</loc>
<lastmod>2015-08-05T17:47:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/790-postponement-of-ispe-malaysia-gmp-conference-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/784-membekal-30-unit-komputer-peribadi-untuk-kegunaan-pegawai-di-biro-pengawalan-farmaseutikal-kebangsaan-kementerian-kesihatan-malaysia-jalan-universiti-petaling-jaya?Itemid=437</loc>
<lastmod>2015-08-05T17:38:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/780-pembaharuan-prosedur-permohonan-variasi-bagi-produk-berdaftar-produk-tradisional-dan-suplemen-kesihatan-quest-2-dan-quest-3?Itemid=437</loc>
<lastmod>2015-08-05T17:34:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/729-invitation-to-the-intersessional-meeting-of-the-accsq-tmhs-pwg-and-its-related-meetings-25-29-aug-bangkok-thailand?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/767-kenyataan-tawaran-sebutharga-kerja-kerja-kecil-pusat-kawalan-kualiti-di-biro-pengawalan-farmaseutikal-kebangsaan-kkm?Itemid=437</loc>
<lastmod>2015-08-05T17:29:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/766-invitation-to-the-21st-accsq-tmhspwg-meeting-23-28-june-siem-reap-cambodia?Itemid=437</loc>
<lastmod>2015-08-05T17:26:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/726-new-publication-reaksi-drug-safety-news-may-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/725-maintenance-schedule-of-quest-2-and-quest-3-system?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/764-produk-kosmetik-yang-dibatalkan-notifikasi-atas-isu-campurpalsu?Itemid=437</loc>
<lastmod>2015-08-05T17:25:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/762-seminar-updates-on-anti-malarial-medicines-mmv?Itemid=437</loc>
<lastmod>2015-08-05T17:24:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/724-new-publication-reaksi-drug-safety-news-july-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/723-majlis-persaraan-bpfk-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/760-21st-asean-consultative-committee-for-standards-and-quality-accsq-pharmaceutical-product-working-group-ppwg?Itemid=437</loc>
<lastmod>2015-08-05T17:18:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/721-slide-presentation-for-analytical-method-validation-and-method-validation-seminar?Itemid=437</loc>
<lastmod>2015-07-30T23:41:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/756-perkhidmatan-sewaan-mesin-fotostat-penyalin-dan-caj-bacaan-meter-bagi-tempoh-dua-2-tahun-di-biro-pengawalan-farmaseutikal-kebangsaan-bpfk-kementerian-kesihatan-malaysia?Itemid=437</loc>
<lastmod>2015-08-05T17:13:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/720-hari-bersama-pelanggan-biro-pengawalan-farmaseutikal-kebangsaan-bpfk-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/719-makluman-jadual-sistem-quest-2-3-offline?Itemid=437</loc>
<lastmod>2015-07-30T23:21:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/751-kerja-kerja-kecil-pusat-kawalan-kualiti-di-biro-pengawalan-farmaseutikal-kebangsaan-kementerian-kesihatan-malaysia-jalan-universiti-petaling-jaya-selangor?Itemid=437</loc>
<lastmod>2015-08-02T20:01:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/716-new-publication-reaksi-drug-safety-news-september-2014?Itemid=437</loc>
<lastmod>2015-07-30T23:12:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/744-semi-manual-submission-procedure-for-applications-for-registration?Itemid=437</loc>
<lastmod>2015-08-05T17:11:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/714-ispe-malaysia-gmp-conference-10-11-february-2015-new-dates-programme-registration-form?Itemid=437</loc>
<lastmod>2015-07-30T23:17:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/741-china-press-majun-burung-unta?Itemid=437</loc>
<lastmod>2015-08-05T00:57:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/713-new-publication-reaksi-drug-safety-news-november-2014?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/43-announcement-2014/712-quest2-and-quest3-service-interruption-31-12-2014-2-1-2015?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/884-the-14th-meeting-of-the-asean-tmhs-scientific-committee-atsc-and-related-meetings-of-the-accsq-tmhs-pwg-task-force?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/883-quest-2-quest-3-system-closure-on-28-april-2012?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/882-quest-3-membership-registration-procedure-change?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/881-classification-of-medical-device-drug-cosmetic-interface-mddci-product?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/880-quest-2-system-shutdown-on-24-26-november-2012?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/879-quest-3-system-shutdown-on-6-7-december-2012?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/877-ulasan-laporan-akhbar-a-pharmaceutical-company-in-india-recalled-a-cholesterol-lowering-drug-found-containing-broken-glass-pieces?Itemid=437</loc>
<lastmod>2015-08-04T00:31:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/52-announcement-2012/878-1st-announcement-national-regulatory-conference-2013?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/905-spesifikasi-baru-untuk-ujian-kontaminasi-mikrobial?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/904-maklumat-lanjutan-tentang-spesifikasi-baru-untuk-ujian-kontaminasi-mikrobial?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/903-pelancaran-modul-penilaian-penuh-quest3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/902-keperluan-penetapan-had-lovastatin-dari-sumber-asli-dalam-produk-semulajadi?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/901-pelancaran-fasa-kedua-sistem-quest3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/899-pelancaran-fasa-ketiga-sistem-quest3?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/896-slid-pembentangan-bagi-taklimat-ringkas-berkenaan-quest-3-modul-ctil-ctx?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/898-senarai-produk-kesihatan-yang-dicampur-palsu-dengan-racun-terkawal?Itemid=437</loc>
<lastmod>2015-08-04T19:23:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/894-garispanduan-pendaftaran-produk-homeopati?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/897-slid-pembentangan-bagi-taklimat-ringkas-berkenaan-quest-3-modul-penilaian-produk-bioteknologi-produk-baru-dan-combo-pack?Itemid=437</loc>
<lastmod>2015-08-04T19:22:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/57-announcement-2010-2/895-slid-pembentangan-bagi-taklimat-pelaksanaan-fasa-ke-enam-6-quest-3-30-nov-2010?Itemid=437</loc>
<lastmod>2015-08-04T19:22:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/893-penguatkuasaan-keperluan-pelesenan-terhadap-premis-pengilang-tempatan-yang-mengilang-produk-veterinar-di-malaysia?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/892-guildelines-on-good-distribution-practice-gdp?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/891-produk-dengan-nama-tuntutan-dan-kegunaan-untuk-melansingkan-badan-tidak-dikelaskan-sebagai-produk-kosmetik?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/890-penggunaan-doktor-gigi-di-dalam-iklan-iklan-produk-pergigian?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/889-regulatory-control-of-active-pharmaceutical-ingredients?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/888-keperluan-mengemukakan-dokumen-sokongan-pengesahan-tahap-pencemaran-radioaktif-bagi-produk-yang-diimport-dari-negara-jepun?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/887-updated-news-on-be?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/886-pengeluaran-sijil-apb-pengilang-kosmetik-kepada-negara-asean?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/56-announcement-2011-2/885-news-on-data-exclusivity?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/64-press-release-2015/914-kenyataan-akhbar-makluman-kepada-orang-awam-berkenaan-dokumen-palsu-surat-arahan-pemberhentian-produk-double-stemcell?Itemid=437</loc>
<lastmod>2016-02-22T18:23:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/64-press-release-2015/655-kosmetik-jenama-hans-beauty-telah-dikesan-mengandungi-racun-berjadual?Itemid=437</loc>
<lastmod>2016-02-22T18:30:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/64-press-release-2015/654-kenyataan-akhbar-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar-maajun-tolak-angin?Itemid=437</loc>
<lastmod>2016-02-22T18:28:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/956-vaccine-lot-release-panduan-bayaran-yuran-dan-slaid-pembentangan?Itemid=437</loc>
<lastmod>2016-02-25T19:39:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/953-new-publication-reaksi-drug-safety-news-september-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/944-quest-system-direct-links?Itemid=437</loc>
<lastmod>2016-02-25T19:39:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/928-notice-preventive-maintenance-works-for-digicert-online-system?Itemid=437</loc>
<lastmod>2016-02-25T19:39:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/935-quest-system-compatibility-issue?Itemid=437</loc>
<lastmod>2016-02-25T19:39:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/926-notice-service-interruption-for-digicert-online-system-on-16-august-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/609-seminar-rtc-kawalan-ubat-tradisional-dan-produk-kosmetik-2015-zon-timur?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/913-seminar-rtc-kawalan-ubat-tradisional-dan-produk-kosmetik-2015-zon-sarawak?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/912-p02-p-an-european-perspective-on-orphan-medicinal-products-bruno-sepodes-august-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/911-presentation-slides-for-day-3-national-regulatory-conference-nrc-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/910-presentation-slides-for-day-2-national-regulatory-conference-nrc-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/909-presentation-slides-for-day-1-national-regulatory-conference-nrc-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/653-invitation-to-the-inter-sessional-meeting-of-the-26th-meeting-of-atsc-19th-meeting-of-tmhs-gmp-task-force-and-19th-meeting-of-tfrf-for-tmhs-18-22-january-2015-mandalay-myanmar?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/652-ispe-malaysia-gmp-conference-10-11-february-2015-programme-registration-form?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/651-technical-error-with-adverse-drug-reaction-email?Itemid=437</loc>
<lastmod>2016-02-25T19:40:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/650-quest2-and-quest3-service-interruption-27-2-2015-1-3-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/649-checklist-for-analytical-method-validation-chemical-and-microbiological?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/646-invitation-to-the-23rd-asean-consultative-committee-for-standards-and-quality-accsq-traditional-medicines-health-supplements-tmhs-and-its-related-meetings-from-1-5th-june-2015-kuala-lumpur?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/648-1st-malaysia-japan-symposium?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/644-updates-on-vaccine-lot-release-in-malaysia?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/643-enhancement-of-capacity-building-for-malaysian-herbal-monograph-team-in-chemical-testing-aspects-workshop?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/641-soal-selidik-kajian-kepuasan-pelanggan-biro-pengawalan-farmaseutikal-kebangsaan-bpfk-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/612-information-updates-on-bioequivalence-be-webpage-june-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/611-national-regulatory-conference-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/610-pre-conference-seminar-to-national-regulatory-conference-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:39:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/69-announcement-2015/746-new-publication-reaksi-drug-safety-news-may-2015?Itemid=437</loc>
<lastmod>2016-10-15T10:21:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/76-quest3/1067-quest3-cosmetic-notification-search?Itemid=437</loc>
<lastmod>2016-10-09T16:04:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/957-new-publication-madrac-bulletin-august-2015?Itemid=437</loc>
<lastmod>2018-06-11T17:55:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/938-madrac-bulletin-april-2015?Itemid=437</loc>
<lastmod>2018-06-11T17:55:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1279-new-publication-madrac-bulletin-issue-3-2017?Itemid=437</loc>
<lastmod>2018-06-11T17:54:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/924-madrac-bulletin-december-2014?Itemid=437</loc>
<lastmod>2018-06-11T17:56:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/728-new-publication-madrac-bulletin-april-2014?Itemid=437</loc>
<lastmod>2018-06-11T17:56:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/717-new-publication-madrac-bulletin-august-2014?Itemid=437</loc>
<lastmod>2018-06-11T17:56:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/753-new-publication-madrac-bulletin-august-2013?Itemid=437</loc>
<lastmod>2018-06-11T17:56:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/749-new-publication-madrac-bulletin-december-2013?Itemid=437</loc>
<lastmod>2018-06-11T17:56:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1211-new-publication-madrac-bulletin-issue-2-2017?Itemid=437</loc>
<lastmod>2018-06-11T17:54:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1192-new-publication-madrac-bulletin-issue-1-2017?Itemid=437</loc>
<lastmod>2018-06-11T17:55:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1139-new-publication-bulletin-madrac-december-2016?Itemid=437</loc>
<lastmod>2018-06-11T17:55:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1118-announcement-new-publication-bulletin-madrac-august-2016?Itemid=437</loc>
<lastmod>2018-06-11T17:55:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/984-new-publication-madrac-bulletin-dec-2015?Itemid=437</loc>
<lastmod>2018-06-11T17:55:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/86-publications/madrac-bulletin/1078-new-publication-bulletin-madrac-april-2016?Itemid=437</loc>
<lastmod>2018-06-11T17:55:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/833-reaksi-drug-safety-news-2013-september-november-issue?Itemid=437</loc>
<lastmod>2018-06-11T18:44:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/950-new-publication-reaksi-drug-safety-news-july-2015?Itemid=437</loc>
<lastmod>2018-06-11T18:44:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/781-reaksi-drug-safety-news-january-2014?Itemid=437</loc>
<lastmod>2018-06-11T18:44:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1240-reaksi-drug-safety-news-2017-issue-6-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/835-reaksi-drug-safety-news-2013-may-july-issue?Itemid=437</loc>
<lastmod>2018-06-11T18:44:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1223-reaksi-drug-safety-news-2017-issue-5-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1191-new-publication-reaksi-drug-safety-news-issue-4-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1190-new-publication-reaksi-drug-safety-news-issue-3-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1163-new-publication-reaksi-drug-safety-news-march-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1134-new-publication-reaksi-drug-safety-news-january-2017?Itemid=437</loc>
<lastmod>2018-06-11T18:41:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1092-new-publication-reaksi-drug-safety-news-september-2016?Itemid=437</loc>
<lastmod>2018-06-11T18:42:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1046-new-publication-reaksi-drug-safety-news-mac-2016?Itemid=437</loc>
<lastmod>2018-06-11T18:42:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/978-new-publication-reaksi-drug-safety-news-november-2015?Itemid=437</loc>
<lastmod>2018-06-11T18:44:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1080-new-publication-reaksi-drug-safety-news-may-2016?Itemid=437</loc>
<lastmod>2018-06-11T18:42:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/87-publications/reaksi-drug-safety-news/1081-new-publication-reaksi-drug-safety-news-july-2016?Itemid=437</loc>
<lastmod>2018-06-11T18:42:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/78-dca-annoucement/1154-conditional-registration-of-a-dengue-vaccine-for-use-in-malaysians-9-45-years-of-age?Itemid=437</loc>
<lastmod>2017-04-05T19:12:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/82-announcement-main/1437-announcement-prescription?Itemid=437</loc>
<lastmod>2018-07-15T18:16:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1115-berita-ubat-ubatan-disember-2016?Itemid=437</loc>
<lastmod>2018-02-05T16:48:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1111-makluman-penutupan-kaunter-unit-hasil-npra?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1105-mopi-gmp-training-2017?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1099-laporan-tahunan-npra-2015?Itemid=437</loc>
<lastmod>2016-12-06T16:11:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1095-seminar-asean-common-technical-dossier-actd-preparation-generic-products-for-malaysian-submission?Itemid=437</loc>
<lastmod>2016-11-24T22:20:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1069-seminar-foreign-gmp-regulatory-inspection-managing-changes-of-licensed-facility?Itemid=437</loc>
<lastmod>2016-09-10T03:09:25Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1068-malaysian-pharmacovigilance-guidelines-2nd-edition?Itemid=437</loc>
<lastmod>2016-10-15T10:10:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1060-updates-on-bioequivalence-be-webpage-august-2016-immediate-release-solid-oral-dosage-form?Itemid=437</loc>
<lastmod>2016-08-18T16:54:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1049-gangguan-talian-telefon-utama-npra?Itemid=437</loc>
<lastmod>2016-10-12T17:25:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1044-pemberitahuan-nama-bpfk-untuk-bank-deraf-kiriman-wang-wang-pos?Itemid=437</loc>
<lastmod>2016-07-19T22:08:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1038-penangguhan-pelancaran-quest3?Itemid=437</loc>
<lastmod>2016-06-29T23:35:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1022-latihan-ispe-tmhs-kosmetik-2-0?Itemid=437</loc>
<lastmod>2016-06-29T22:38:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1008-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-bentuk-dos-oral-berkuatkuasa-1-jul-2016?Itemid=437</loc>
<lastmod>2016-04-27T20:21:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/989-format-laporan-tindakan-pembetulan-dan-tindakan-pencegahan-capa-dan-nota-penerangan-format-laporan-capa?Itemid=437</loc>
<lastmod>2016-03-21T18:40:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/986-list-of-recognized-private-laboratories-for-testing-of-traditional-products?Itemid=437</loc>
<lastmod>2016-03-21T19:18:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/983-latihan-ispe-tmhs-dan-kosmetik?Itemid=437</loc>
<lastmod>2016-02-29T17:21:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/982-slides-for-regulatory-updates-2016?Itemid=437</loc>
<lastmod>2016-02-25T19:17:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/975-good-distribution-practice-gdp-for-transporters?Itemid=437</loc>
<lastmod>2016-02-25T19:27:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/971-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-bentuk-dos-oral-berkuatkuasa-1-julai-2016?Itemid=437</loc>
<lastmod>2016-02-25T19:10:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/969-updates-on-biowaiver-webpage-generic-product-list-for-be-studies?Itemid=437</loc>
<lastmod>2016-02-25T19:09:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/967-list-of-cosmetic-manufacturer-in-malaysia-that-conforms-to-the-requirement-of-good-manufacturing-practices-gmp-in-accordance-to-the-asean-guideline-for-cosmetic-good-manufacturing-practice?Itemid=437</loc>
<lastmod>2016-02-25T19:06:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/965-perintah-cukai-barang-dan-perkhidmatan-pembekalan-berkadar-sifar-pindaan-no-2-2015?Itemid=437</loc>
<lastmod>2016-02-25T19:08:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/961-international-good-manufacturing-practice-training-program-2016?Itemid=437</loc>
<lastmod>2016-02-25T19:07:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/951-online-adverse-drug-reaction-adr-reporting-interruption?Itemid=437</loc>
<lastmod>2017-07-25T16:24:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/36-announcement-main/announcement-2016/1086-soal-selidik-kajian-kepuasan-pelanggan-agensi-regulatori-farmasi-negara-2016?Itemid=437</loc>
<lastmod>2016-10-17T17:01:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1116-penutupan-penerimaan-pendaftaran-secara-manual?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1107-pra-pelancaran-sistem-quest3?Itemid=437</loc>
<lastmod>2016-12-26T17:06:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1106-user-manual-quest3-system?Itemid=437</loc>
<lastmod>2016-12-15T18:06:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1071-scheduled-maintenance-for-quest3-system?Itemid=437</loc>
<lastmod>2016-10-23T16:22:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1065-quest2-products-renewal?Itemid=437</loc>
<lastmod>2016-09-04T16:28:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1074-slide-taklimat-pengenalan-latihan-sistem-quest3?Itemid=437</loc>
<lastmod>2016-11-23T20:28:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1062-b2b-payment-online-transaction-flow?Itemid=437</loc>
<lastmod>2016-08-29T23:05:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1057-pembukaan-semula-pembayaran-online-untuk-sistem-quest3?Itemid=437</loc>
<lastmod>2016-08-03T22:17:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1055-pelancaran-modul-kosmetik-notifikasi-quest3-2?Itemid=437</loc>
<lastmod>2016-08-02T22:02:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1054-user-manual-for-quest3-digital-certificate?Itemid=437</loc>
<lastmod>2016-12-07T00:01:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1050-pelancaran-modul-kosmetik-notifikasi-quest3?Itemid=437</loc>
<lastmod>2016-07-31T18:36:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1045-online-payment-for-quest3-updated-20-07-2016?Itemid=437</loc>
<lastmod>2016-07-19T22:12:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1039-penangguhan-pelancaran-quest3-2?Itemid=437</loc>
<lastmod>2016-06-29T23:37:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1042-online-payment-for-quest3-2?Itemid=437</loc>
<lastmod>2016-07-19T20:05:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1012-quest2-products-renewal-during-moratorium-period?Itemid=437</loc>
<lastmod>2016-05-25T23:53:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1017-product-search-for-quest2?Itemid=437</loc>
<lastmod>2016-05-26T18:45:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1013-pengumuman-tempoh-akhir-mengemukakan-dokumen-bagi-permohonan-baru-dan-variasi-pendaftaran-produk-sempena-moratorium-sistem-quest?Itemid=437</loc>
<lastmod>2016-05-25T23:52:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1009-closure-of-quest-3-new-membership-application?Itemid=437</loc>
<lastmod>2016-05-25T23:50:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/71-announcement-main/announcement-2016/quest3-announcement-2016/1007-quest-3-plus-updates-slides?Itemid=437</loc>
<lastmod>2016-05-25T23:56:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/190-announcement-main/announcement-general/1288-national-regulatory-conference-nrc-2018?Itemid=437</loc>
<lastmod>2018-07-26T23:08:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1148-mozilla-firefox-version-51-0?Itemid=437</loc>
<lastmod>2018-09-26T17:15:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1132-permohonan-pendaftaran-semula-pertukaran-pemegang-pendaftaran-dan-certificate-of-pharmaceutical-product-cpp-secara-atas-talian-melalui-sistem-quest-3?Itemid=437</loc>
<lastmod>2018-09-26T17:16:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1125-pemberitahuan-permohonan-lesen-pengilang-lesen-mengimport-lesen-pemborong-senarai-tambahan-produk-sijil-apb-dan-pemeriksaan-apb-bukan-rutin-secara-perkhidmatan-dalam-talian-menggunakan-sistem-quest3?Itemid=437</loc>
<lastmod>2018-09-26T17:16:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1247-makluman-penutupan-kaunter-kutipan-dan-terimaan-hasil-berikutan-penutupan-akaun-utama-pada-28-dis-2017-hingga-5-januari-2018?Itemid=437</loc>
<lastmod>2018-09-26T16:46:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1244-proses-pendaftaran-pengguna-untuk-sistem-pendaftaran-produk-perlesenan-quest-3?Itemid=437</loc>
<lastmod>2018-09-26T16:47:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1239-mopi-gmp-training-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:07:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1238-surat-peringatan-pendaftaran-semula-produk?Itemid=437</loc>
<lastmod>2018-09-26T17:08:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1236-penutupan-pembayaran-online-untuk-sistem-quest3-bagi-penutup-tahun-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:08:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1235-panggilan-sesi-dialog-perbincangan-draf-garis-panduan-amalan-pengedaran-baik-aeb-edisi-ketiga-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:08:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1234-updates-on-bioequivalence-webpage-112017?Itemid=437</loc>
<lastmod>2018-09-26T17:09:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1233-pembukaan-section-s-e13-untuk-variation?Itemid=437</loc>
<lastmod>2018-09-26T17:09:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1231-workflow-for-manual-registration-of-for-export-only-feo-products-2?Itemid=437</loc>
<lastmod>2018-09-26T17:09:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1229-seranta-awam-draf-garis-panduan-amalan-pengedaran-baik-edisi-ke-3-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:09:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1220-ispe-malaysia-gmp-gdp-inspection-on-biopharmaceuticals-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:10:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1212-pelaksanaan-proses-kerja-baharu-pemeriksaan-rangkaian-sejuk-bagi-aktiviti-vaccine-dan-plasma-product-lot-release-di-malaysia?Itemid=437</loc>
<lastmod>2018-09-26T17:10:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1210-seminar-rtc-kawalan-ubat-ubatan-tradisional-dan-kosmetik-bernotifikasi-2017-zon-sabah-2?Itemid=437</loc>
<lastmod>2018-09-26T17:10:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1209-penutupan-sistem-quest3?Itemid=437</loc>
<lastmod>2018-09-26T17:11:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1207-pembukaan-pembaharuan-lesen-keluaran-berdaftar-pengilang-mengimport-pemborong-untuk-tahun-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:11:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1204-draf-cadangan-good-compounding-practice-first-edition-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:11:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1202-cleanroom-behaviour-course?Itemid=437</loc>
<lastmod>2018-09-26T17:11:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1199-pengumuman-mengenai-kawalan-produk-persediaan-parenteral-sebagai-racun-di-bawah-akta-racun-1952?Itemid=437</loc>
<lastmod>2018-09-26T17:12:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1198-gentle-reminder-renewal-of-product-registration?Itemid=437</loc>
<lastmod>2018-09-26T17:12:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1197-updates-on-bioequivalence-webpage?Itemid=437</loc>
<lastmod>2018-09-26T17:12:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1193-pemakluman-berkenaan-parking-pelawat?Itemid=437</loc>
<lastmod>2018-09-26T17:12:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1183-migrasi-data-berperingkat-untuk-sistem-quest3?Itemid=437</loc>
<lastmod>2018-09-26T17:13:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1167-pengumuman-berkenaan-penghantaran-borang-beserta-pembayaran-bagi-pengkelasan-pendaftaran-produk-untuk-tujuan-eksport-feo-sijil-indikasi-sijil-deklarasi?Itemid=437</loc>
<lastmod>2018-09-26T17:13:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1165-seranta-awam-cadangan-pindaan-peraturan-peraturan-kawalan-dadah-kosmetik-1984-pkdk-1984?Itemid=437</loc>
<lastmod>2018-09-26T17:13:52Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1161-updates-on-bioequivalence-be-webpage?Itemid=437</loc>
<lastmod>2018-09-26T17:14:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1153-pengumuman-mengenai-penguatkuasaan-yuran-pemprosesan-permohonan-variasi-produk-pada-1-april-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:14:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1151-drug-registration-guidance-document-drgd-second-edition-september-2016-revised-march-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:14:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1147-hari-bersama-pelanggan-bahagian-regulatori-farmasi-negara-npra-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:15:14Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1140-cosmetic-seminar-2017-28th-29th-march-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:15:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1138-seminar-rtc-kawalan-ubat-tradisional-dan-produk-kosmetik-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:15:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/211-announcement-main/announcement-2017/1122-awasi-produk-tidak-berdaftar?Itemid=437</loc>
<lastmod>2018-09-26T17:17:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1168-quest3-system-is-now-compatible-for-google-chrome-browser?Itemid=437</loc>
<lastmod>2018-09-26T17:13:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1292-2018-education-seminar-series-good-distribution-practice-gdp?Itemid=437</loc>
<lastmod>2018-09-26T17:03:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1296-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-semua-bentuk-dos-berkuatkuasa-1-julai-2018a?Itemid=437</loc>
<lastmod>2018-09-26T17:02:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1299-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftran-baru-pendaftaran-semula-produk-farmaseutiakl-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd-2?Itemid=437</loc>
<lastmod>2018-09-26T17:02:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1613-latihan-tmhs-product-quality-review-pqr-dan-verifikasi?Itemid=437</loc>
<lastmod>2018-09-26T17:02:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1291-berita-ubat-ubatan-march-2018-volume-71?Itemid=437</loc>
<lastmod>2018-09-26T17:03:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1614-promosi-penjualan-monograf-herba-malaysia-2015?Itemid=437</loc>
<lastmod>2018-09-26T17:02:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1290-berita-ubat-ubatan-december-2017-volume-70?Itemid=437</loc>
<lastmod>2018-09-26T17:03:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1615-nrc-2018-post-conference-seminar-on-who-good-practices-for-desk-assessment-for-compliance-with-gmp-gcp-glp?Itemid=437</loc>
<lastmod>2018-09-26T17:01:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1289-berita-ubat-ubatan-september-2017-volume-69?Itemid=437</loc>
<lastmod>2018-09-26T17:04:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1617-2018-education-seminar-series-analysis-of-findings-from-gmp-inspections-of-pharmaceutical-manufacturers-introduction-to-guidance-document-of-pre-approval-gmp-inspection?Itemid=437</loc>
<lastmod>2018-09-26T17:01:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1287-latihan-untuk-industri-pemeriksaan-apb-pengilang-veterinar?Itemid=437</loc>
<lastmod>2018-09-26T17:04:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1618-penyerahan-laporan-kajian-bioekuivalens-be-bagi-produk-produk-generik-berdaftar-dalam-bentuk-effervescent-dispersible-orodispersible-sublingual-buccal-dan-chewable-tablet-kapsul-untuk-tujuan-pendaftaran-semula-direktif-bil-27-dlm-bpfk-ppp-07-25?Itemid=437</loc>
<lastmod>2018-09-26T17:01:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1286-makluman-scam-panggilan-telefon?Itemid=437</loc>
<lastmod>2018-09-26T17:04:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1621-updates-on-bioequivalence-be-webpage-august-2018-immediate-release-solid-oral-dosage-form?Itemid=437</loc>
<lastmod>2018-09-26T17:00:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1285-new-safety-alerts-for-healthcare-professionals?Itemid=437</loc>
<lastmod>2018-09-26T17:04:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1622-peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-tempoh-pendaftaran-mulai-1-januari-2020?Itemid=437</loc>
<lastmod>2018-09-26T17:00:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1280-quest3-system-usb-token-package?Itemid=437</loc>
<lastmod>2018-09-26T17:05:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1626-new-publication-madrac-bulletin-issue-01-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:00:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1639-penipuan-kutipan-derma?Itemid=437</loc>
<lastmod>2018-09-26T16:55:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1276-housekeeping-quest3-system?Itemid=437</loc>
<lastmod>2018-09-26T17:05:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1275-updates-on-foreign-gmp-regulatory-inspection-2019?Itemid=437</loc>
<lastmod>2018-09-26T17:05:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1273-application-of-combination-pack-combo-pack?Itemid=437</loc>
<lastmod>2018-09-26T17:05:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1264-gentle-reminder-application-for-product-registration?Itemid=437</loc>
<lastmod>2018-09-26T17:06:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1261-berita-ubat-ubatan-jun-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:06:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1260-berita-ubat-ubatan-jun-2017?Itemid=437</loc>
<lastmod>2018-09-26T17:06:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1252-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-semua-bentuk-dos-berkuatkuasa-1-julai-2018?Itemid=437</loc>
<lastmod>2018-09-26T17:06:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/212-announcement-main/announcement-2018/1248-lanjutan-tarikh-pelaksanaan-pemakaian-guideline-for-regsitration-of-drug-medical-device-and-medical-device-drug-combination-products?Itemid=437</loc>
<lastmod>2018-09-26T17:07:34Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/593-tykerb-lapatinib-comparative-data-have-shown-that-lapatinib-based-regimens-are-less-effective-than-trastuzumab-based-regimens-for-metastatic-breast-cancer-mbc-in-certain-settings?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/592-concerta-methylphenidate-hydrochloride-new-warning-on-priapism-in-patients-treated-for-attention-deficit-hyperactivity-disorder-adhd?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/591-zofran-ondansetron-dose-dependent-qt-interval-prolongation-updated-information-on-posology-for-intravenous-iv-use-in-the-prevention-of-chemotherapy-induced-nausea-and-vomiting-cinv?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/590-erbitux-cetuximab-importance-of-establishing-wild-type-ras-status-exons-2-3-4-of-kras-and-nras-before-treatment-in-metastatic-colorectal-cancer-mcrc?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/589-ultracet-tablet-tramadol-and-paracetamol-association-with-serious-skin-reactions-stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/588-frisium-clobazam-update-to-include-serious-skin-reactions-in-package-insert-for-malaysia?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/587-combination-products-containing-cyproterone-acetate-2mg-and-ethinylestradiol-0-035mg-restriction-of-indication-and-measures-to-reduce-risk-of-thromboembolism?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/586-dilatrend-carvedilol-warning-on-severe-adverse-cutaneous-reactions?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/585-risperidone-and-paliperidone-risk-of-intraoperative-floppy-iris-syndrome-ifis-in-patients-undergoing-cataract-surgery?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/584-vectibix-panitumumab-rare-cases-of-stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten-have-been-reported-in-patients-treated-with-vectibix?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/583-mencevaxacwy-meningococcal-vaccine-new-antibody-persistence-data?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/581-ritalin-and-ritalin-la-methylphenidate-hydrochloride-new-warning-on-priapism-in-patients-treated-for-attention-deficit-hyperactivity-disorder-adhd-date-08-july-2014?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/580-gran-filgrastim-peglasta-pegfilgrastim-risk-of-capillary-leak-syndrome-in-patients-with-cancer-filgastrim-pegfilgastrim-and-in-healthy-donors-filgastrim-only?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/579-protaxos-strontium-ranelate-new-restricted-indication-and-contraindications-for-use?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/578-neupogen-filgrastim-neulastim-pegfilgrastim-risk-of-capillary-leak-syndrome-in-patients-with-cancer-filgastrim-pegfilgastrim-and-in-healthy-donors-filgastrim-only?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/577-revatio-sildenafil-citrate-safety-information-regarding-revatio-tablets-for-the-treatment-of-pulmonary-arterial-hypertension-pah?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/576-topamax-topiramate-updated-warnings-and-precautions-on-visual-field-defects?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/59-safety-alerts-main/safety-alert-2014/575-reminyl-galantaminehydrobromide-new-warning-serious-skin-reactions-stevens-johnson-syndrome-sjs-and-acute-generalised-exanthematous-pustulosis-agep?Itemid=437</loc>
<lastmod>2015-08-04T23:21:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/32-safety-alerts-main/safety-alert-2015/942-forxiga-dapagliflozin-risk-of-diabetic-ketoacidosis-during-treatment-with-sodium-glucose-co-transporter-2-sglt2-inhibitor-dapagliflozin?Itemid=437</loc>
<lastmod>2016-01-11T17:49:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/32-safety-alerts-main/safety-alert-2015/970-cellcept-mycophenolate-mofetil-teratogenic-risk-important-new-pregnancy-prevention-advice-for-women-and-men?Itemid=437</loc>
<lastmod>2016-01-11T17:54:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/32-safety-alerts-main/safety-alert-2015/941-motilium-domperidone-new-recommendations-to-minimise-cardiac-risks?Itemid=437</loc>
<lastmod>2016-01-11T17:55:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/32-safety-alerts-main/safety-alert-2015/574-artrodar-50mg-diacerein-new-restrictions-of-use-to-limit-the-risk-of-severe-diarrhoea-and-effects-on-the-liver?Itemid=437</loc>
<lastmod>2016-01-11T17:55:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/32-safety-alerts-main/safety-alert-2015/573-xgeva-120mg-solution-for-injection-denosumab-updated-recommendations-to-minimise-the-risk-of-severe-symptomatic-hypocalcaemia-ssh-and-osteonecrosis-of-the-jaw-onj?Itemid=437</loc>
<lastmod>2016-01-11T17:56:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1094-implanon-nxt-etonogestrel-implants-have-been-found-rarely-in-the-vasculature-and-lung-an-update-on-possible-risks-and-complications-regarding-insertion-localisation-removal-and-migration?Itemid=437</loc>
<lastmod>2016-11-23T19:56:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1142-zaltrap-aflibercept-information-on-the-risk-of-osteonecrosis-of-the-jaw?Itemid=437</loc>
<lastmod>2017-02-27T20:36:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1093-invokana-canagliflozin-advice-on-the-risk-of-lower-limb-amputation-primarily-of-the-toe-during-treatment-with-canagliflozin-containing-medicines?Itemid=437</loc>
<lastmod>2016-11-23T19:57:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1061-tarceva-erlotinib-first-line-maintenance-indication-now-restricted-to-treatment-of-patients-whose-tumours-harbour-an-egfr-activating-mutation?Itemid=437</loc>
<lastmod>2016-08-23T23:22:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1056-adempas-riociguat-new-contraindication-for-patients-with-pulmonary-hypertension-associated-with-idiopathic-interstitial-pneumonias-ph-iip?Itemid=437</loc>
<lastmod>2016-08-02T23:05:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1033-locabiotal-solution-fusafungine-withdrawal-of-registration-following-european-medicines-agency-s-benefit-risk-assessment?Itemid=437</loc>
<lastmod>2016-06-07T17:11:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1029-xgeva-120mg-prolia-60mg-denosumab-clinically-significant-cases-of-hypercalcaemia-after-cessation-of-treatment-with-denosumab-in-paediatric-patients?Itemid=437</loc>
<lastmod>2016-06-07T17:04:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1032-glivec-imatinib-tasigna-nilotinib-risk-of-hepatitis-b-reactivation?Itemid=437</loc>
<lastmod>2016-06-07T17:11:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1031-xalkori-crizotinib-inclusion-of-a-new-warning-regarding-cardiac-failure?Itemid=437</loc>
<lastmod>2016-06-07T17:11:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/58-safety-alerts-main/safety-alert-2016/1030-viekirax-ombitasvir-paritaprevir-ritonavir-with-or-without-exviera-dasabuvir-not-recommended-in-child-pugh-b-patients?Itemid=437</loc>
<lastmod>2016-06-07T17:04:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1265-xofigo-radium-223-dichloride-important-safety-information-update-regarding-increased-incidence-of-deaths-and-fractures-in-a-randomized-clinical-trial-with-xofigo-used-in-combination-with-abiraterone-acetate-and-prednisolone-prednisone?Itemid=437</loc>
<lastmod>2018-02-22T00:20:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1222-ribomustin-bendamustine-increased-mortality-observed-when-used-in-non-approved-combination-treatments-or-outside-the-approved-indications-monitor-for-opportunistic-infections-and-hepatitis-b-reactivation?Itemid=437</loc>
<lastmod>2017-10-05T16:53:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1221-xgeva-denosumab-risk-of-multiple-vertebral-fractures-mvf-following-treatment-discontinuation?Itemid=437</loc>
<lastmod>2017-10-05T23:05:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1185-keytruda-pembrolizumab-risk-of-stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten?Itemid=437</loc>
<lastmod>2017-07-02T23:08:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1184-zelboraf-vemurafenib-important-drug-warning-risk-of-dupuytren-s-contracture-and-plantar-fascial-fibromatosis?Itemid=437</loc>
<lastmod>2017-07-02T23:07:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1180-domide-thalidomide-new-important-advice-regarding-viral-reactivation-and-pulmonary-hypertension?Itemid=437</loc>
<lastmod>2017-06-04T17:07:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1179-revlimid-lenalidomide-new-important-advice-regarding-viral-reactivation?Itemid=437</loc>
<lastmod>2017-06-04T16:42:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1158-madonna-levonorgestrel-levonorgestrel-containing-emergency-hormonal-contraception-new-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy?Itemid=437</loc>
<lastmod>2017-04-10T20:20:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1157-escapelle-postinor-2-levonorgestrel-levonorgestrel-containing-emergency-hormonal-contraception-new-advice-for-users-of-hepatic-enzyme-inducers?Itemid=437</loc>
<lastmod>2017-04-10T20:21:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/74-safety-alerts-main/safety-alert-2017/1143-pomalyst-pomalidomide-new-important-advice-hepatitis-b-virus-status-to-be-established-before-initiating-treatment-with-pomalidomide?Itemid=437</loc>
<lastmod>2017-02-27T20:28:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1434-efavirenz-risk-of-qtcinterval-prolongation?Itemid=437</loc>
<lastmod>2018-06-24T23:31:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1620-iodinated-contrast-media-risk-of-severe-cutaneous-adverse-reactions-scar?Itemid=437</loc>
<lastmod>2018-08-29T20:48:01Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1433-acetazolamide-risk-of-severe-cutaneous-adverse-reactions-scars?Itemid=437</loc>
<lastmod>2018-06-24T23:21:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1627-stilnox-10mg-film-coated-tablet-zolpidem-restriction-of-indication?Itemid=437</loc>
<lastmod>2018-07-29T09:24:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1297-esmya-5mg-tablets-ulipristal-acetate-women-taking-esmya-for-uterine-fibroids-to-have-regular-liver-tests-while-safety-review-is-ongoing-do-not-initiate-treatment-in-new-patients-or-those-who-have-completed-a-previous-treatment-course?Itemid=437</loc>
<lastmod>2018-04-23T19:24:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1628-domperidone-clarithromycin-drug-interaction-leading-to-increased-risk-of-qt-interval-prolongation?Itemid=437</loc>
<lastmod>2018-07-29T20:37:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1284-doxycycline-risk-of-jarisch-herxheimer-reaction?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1629-noradrenaline-stress-cardiomyopathy?Itemid=437</loc>
<lastmod>2018-07-29T20:37:35Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1645-amoxicillin-containing-products-risk-of-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-and-strengthening-the-risk-of-severe-cutaneous-adverse-reactions-scars?Itemid=437</loc>
<lastmod>2018-06-26T00:51:38Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1646-carbocisteine-and-acetylcysteine-anaphylactic-anaphylactoid-reactions-and-severe-cutaneous-adverse-reactions-scars?Itemid=437</loc>
<lastmod>2018-06-26T00:43:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1283-gadolinium-based-contrast-agents-suspension-restriction-of-use-following-evidence-of-gadolinium-deposits-in-the-brain-after-magnetic-resonance-imaging-mri-body-scans?Itemid=437</loc>
<lastmod>2018-03-22T17:25:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1647-drug-interaction-of-oral-contraceptives-containing-ethinylestradiol-with-the-direct-acting-antiviral-combinations-of-paritaprevir-ritonavir-and-ombitasvir-with-or-without-dasabuvir?Itemid=437</loc>
<lastmod>2018-06-26T00:53:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1648-mesalazine-risk-of-photosensitivity-reactions?Itemid=437</loc>
<lastmod>2018-06-26T00:52:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1282-intravenous-iv-fluids-containing-electrolytes-and-or-carbohydrates-risk-of-hyponatraemia?Itemid=437</loc>
<lastmod>2018-03-22T16:42:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1649-methotrexate-pulmonary-alveolar-haemorrhage?Itemid=437</loc>
<lastmod>2018-06-26T00:52:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1650-pemetrexed-risk-of-nephrogenic-diabetes-insipidus-and-renal-tubular-necrosis?Itemid=437</loc>
<lastmod>2018-06-26T00:51:56Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1281-levetiracetam-and-methotrexate-risk-of-drug-drug-interaction?Itemid=437</loc>
<lastmod>2018-09-27T16:47:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1266-ofev-nintedanib-information-on-severe-liver-injury-and-the-need-for-regular-monitoring-of-liver-function-associated-with-the-use-in-patients-with-idiopathic-pulmonary-fibrosis-ipf?Itemid=437</loc>
<lastmod>2018-02-22T00:28:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1652-propofol-and-sodium-valproate-risk-of-increased-propofol-blood-level-when-co-administered-with-valproate?Itemid=437</loc>
<lastmod>2018-06-26T00:51:14Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1653-efavirenz-risk-of-qtcinterval-prolongation?Itemid=437</loc>
<lastmod>2018-06-26T00:49:10Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/79-safety-alerts-main/safety-alert-2018/1654-acetazolamide-risk-of-severe-cutaneous-adverse-reactions-scars?Itemid=437</loc>
<lastmod>2018-06-24T23:20:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1589-submission-of-bioequvalence-be-study-reports-for-registered-generic-products-in-the-form-of-effervescent-dispersible-orodispersible-sublingual-buccal-and-chewable-tablets-capsules-for-the-purpose-of-re-registration-renewal</loc>
<lastmod>2018-09-04T22:45:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1588-peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-tempoh-pendaftaran-mulai-1-januari-2020</loc>
<lastmod>2018-09-04T22:45:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1398-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftaran-baru-pendaftaran-semula-produk-farmaseutikal-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd</loc>
<lastmod>2018-09-24T19:57:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1397-national-regulatory-conference-nrc-2018</loc>
<lastmod>2018-06-03T16:01:36Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1396-makluman-scam-panggilan-telefon</loc>
<lastmod>2018-04-06T00:50:13Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1395-updated-on-token-price-package</loc>
<lastmod>2018-03-18T17:17:47Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1394-check-addresses-registered-under-company-to-ensure-there-is-no-duplicated-address-or-inactive-address</loc>
<lastmod>2018-03-12T17:04:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1391-gentle-reminder-application-for-product-registration</loc>
<lastmod>2018-02-11T19:34:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1387-pengumuman-mengenai-penguatkuasaan-yuran-pemprosesan-permohonan-variasi-produk-pada-1-april-2017</loc>
<lastmod>2018-01-31T23:15:48Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1383-variation-open-for-section-e13-section-s</loc>
<lastmod>2018-01-31T23:30:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1386-penutupan-sistem-lama-quest3</loc>
<lastmod>2018-01-31T23:14:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1385-workflow-for-manual-registration-of-for-export-only-feo-products</loc>
<lastmod>2018-01-31T23:13:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1384-enable-export-button-using-google-chrome</loc>
<lastmod>2018-01-31T23:12:21Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1382-data-cleaning-open-for-approved-products-submit-manually</loc>
<lastmod>2018-01-31T20:10:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1381-online-payment-closure-for-end-of-year-2017</loc>
<lastmod>2018-01-31T20:06:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1380-surat-peringatan-pendaftaran-semula-produk</loc>
<lastmod>2018-01-31T20:05:39Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1379-pelancaran-modul-feo-for-export-only-di-sistem-quest3</loc>
<lastmod>2018-01-31T20:04:28Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1377-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-semua-bentuk-dos-berkuatkuasa-1-julai-2018</loc>
<lastmod>2018-01-31T20:02:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1378-update-on-e-13-field-for-approved-product</loc>
<lastmod>2018-01-31T20:03:38Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1376-jadual-tempoh-permohonan-tempoh-kemaskini-bagi-data-cleaning</loc>
<lastmod>2018-05-13T20:29:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1365-quest3-system-security-upgrade</loc>
<lastmod>2018-03-19T19:22:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/industry-news-announcements/1364-reminder-for-successful-payment-status</loc>
<lastmod>2018-01-30T00:10:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/89-industries/laboratory-quality-control/1427-makmal-swasta-yang-mematuhi-keperluan-npra-bagi-pengujian-produk-tradisional?Itemid=437</loc>
<lastmod>2018-06-11T23:43:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/90-industries/bioequivalence/1428-information-on-be?Itemid=437</loc>
<lastmod>2018-06-12T06:50:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/faq-generic-medicines/1509-step-3-screening</loc>
<lastmod>2018-07-23T17:56:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/faq-generic-medicines/1487-step-1-pre-submission-of-application-preparation</loc>
<lastmod>2018-09-25T18:54:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/96-regulation-basic/1592-internet-borwser-configuration-for-quest3-system?Itemid=437</loc>
<lastmod>2018-09-06T09:55:57Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/96-regulation-basic/1500-step-1-3-b-patent-and-data-exclusivity-status?Itemid=437</loc>
<lastmod>2018-07-16T22:45:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1537-direktif-untuk-memperketatkan-indikasi-semua-produk-ketoconazole-oral-dan-mengehadkan-penggunaan-di-hospital-sahaja-berikutan-risiko-kesan-advers-hepatotoksisiti?Itemid=437</loc>
<lastmod>2018-08-29T19:38:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1517-direktif-untuk-penggunaan-drug-registration-guidance-document-drgd-second-edition-september-2016-revised-july-2018?Itemid=437</loc>
<lastmod>2018-07-18T17:41:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1511-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftran-baru-pendaftaran-semula-produk-farmaseutiakl-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd?Itemid=437</loc>
<lastmod>2018-07-16T23:55:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1507-direktif-untuk-semua-produk-yang-mengandungi-acetazolamide-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-severe-cutaneous-adverse-reactions-scars?Itemid=437</loc>
<lastmod>2018-07-16T23:26:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1506-direktif-untuk-semua-produk-yang-mengandungi-prednisone-dan-prednisolone-kecuali-persediaan-topikal-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-scleroderma-renal-crisis?Itemid=437</loc>
<lastmod>2018-07-16T23:23:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1505-direktif-untuk-semua-produk-yang-mengandungi-efavirenz-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-qtc-prolongation?Itemid=437</loc>
<lastmod>2018-07-16T23:23:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1504-direktif-untuk-semua-produk-yang-mengandungi-doxycycline-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-jarisch-herxheimer-reaction?Itemid=437</loc>
<lastmod>2018-07-16T23:20:45Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1503-direktif-permohonan-pendaftaran-semula-produk-yang-pernah-didaftarkan-secara-pendaftaran-hak-dan-produk-not-commercially-viable-medicine-ncvm?Itemid=437</loc>
<lastmod>2018-07-16T23:11:02Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1501-for-the-purpose-of-registration-of-generic-products-prh-shall-provide-patent-declarations-as-below-i-prh-shall-comply-with-all-legal-provisions-in-malaysia-ii-the-government-authority-is-not-liable-for-any-offence-committed-by-the-prh-as-a-result-of-any-breach-of-any-law-and-iii-prh-shall-indemnify-the-government-if-any-claim-is-made-against-the-government-as-a-result-of-any-breach-of-any-law-by-t?Itemid=437</loc>
<lastmod>2018-07-16T22:46:18Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1271-direktif-untuk-semua-produk-yang-mengandungi-gabapentin-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-respiratory-depression?Itemid=437</loc>
<lastmod>2018-07-17T00:19:59Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1295-direktif-untuk-semua-produk-yang-mengandungi-carbocisteine-dan-acetylcysteine-pengemaskinian-label-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-maklumat-keselamatan-berkaitan-anaphylactic-anaphylactoid-reaction-dan-severe-cutaneous-adverse-reactions-scar?Itemid=437</loc>
<lastmod>2018-07-17T00:03:15Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1270-direktif-untuk-semua-produk-yang-mengandungi-amoxicillin-termasuk-kombinasi-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-memperkukuhkan-maklumat-berkaitan-severe-cutaneous-adverse-reactions-scars-pada-bahagian-warnings-precautions-dan-amaran-berkaitan-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-pada-bahagian-side-effects?Itemid=437</loc>
<lastmod>2018-07-17T00:25:19Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1294-direktif-untuk-semua-produk-yang-mengandungi-ethinylestradiol-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-risiko-peningkatan-paras-alanine-transaminase-alt-akibat-interaksi-dengan-produk-kombinasi-ombitasvir-paritaprevir-ritonavir-dan-dasabuvir?Itemid=437</loc>
<lastmod>2018-07-16T20:35:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1293-direktif-untuk-semua-produk-yang-mengandungi-mesalazine-pengemaskinian-sisip-bungkusan-dan-risalah-maklumat-ubat-untuk-pengguna-rimup-dengan-amaran-kesan-advers-photosensitivity?Itemid=437</loc>
<lastmod>2018-07-17T00:15:00Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/99-regulation-basic/directive-general/1272-direktif-penambahan-kenyataan-amaran-bagi-semua-produk-yang-mengandungi-boswellia-spp?Itemid=437</loc>
<lastmod>2018-07-16T20:34:20Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/guidelines/1481-guidelines-on-good-manufacturing-practice-for-traditional-medicines-and-health-supplement</loc>
<lastmod>2018-07-16T18:34:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1587-post-marketing-activities?Itemid=437</loc>
<lastmod>2018-09-26T19:27:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1520-step-4-post-registration-process?Itemid=437</loc>
<lastmod>2018-09-25T18:56:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1543-guidelines-for-the-establishment-handling-storage-and-use-of-chemical-reference-substances?Itemid=437</loc>
<lastmod>2018-07-22T23:39:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1539-malaysia-variation-guideline-for-pharmaceutical-products-2013-first-edition?Itemid=437</loc>
<lastmod>2018-07-22T23:13:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1538-site-master-file-third-edition-2014?Itemid=437</loc>
<lastmod>2018-07-22T22:55:55Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1536-guideline-on-good-distribution-practice-third-edition-2018?Itemid=437</loc>
<lastmod>2018-07-22T22:48:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1535-supplementary-notes-on-annex-1-management-of-time-and-temperature-sensitive-products-ttsp-of-guideline-on-good-distribution-practice?Itemid=437</loc>
<lastmod>2018-07-22T22:41:41Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/138-guidelines-central/guidelines-general/1515-garispanduan-pelaksanaan-rimup-edisi-ketiga-julai-2018?Itemid=437</loc>
<lastmod>2018-07-18T16:26:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/139-guidelines-central/guidelines-prescriptions/1557-variation-application-for-pharmaceutical-products?Itemid=437</loc>
<lastmod>2018-07-24T23:08:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1554-variation-application-for-biological-products?Itemid=437</loc>
<lastmod>2018-07-24T22:56:05Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1542-guidance-document-and-guidelines-for-registration-of-biosimilars-in-malaysia?Itemid=437</loc>
<lastmod>2018-07-22T23:36:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1534-guidance-note-for-biological-products-facility-establishment-in-malaysia?Itemid=437</loc>
<lastmod>2018-07-22T22:28:16Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1532-good-tissue-practice-guideline?Itemid=437</loc>
<lastmod>2018-07-22T22:23:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1533-guidance-document-and-guidelines-for-registration-of-cell-and-gene-therapy-products-cgtps-in-malaysia?Itemid=437</loc>
<lastmod>2018-07-22T22:26:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1529-site-master-file-smf-be-for-blood-establishments-in-malaysia?Itemid=437</loc>
<lastmod>2018-07-22T20:42:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/140-guidelines-central/guidelines-biologics/1528-malaysian-variation-guideline-for-biologics-mvgb?Itemid=437</loc>
<lastmod>2018-07-22T18:52:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/142-guidelines-central/guidelines-traditional/1678-natural-products?Itemid=437</loc>
<lastmod>2018-09-26T05:59:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/142-guidelines-central/guidelines-traditional/1555-variation-application-for-health-supplement-and-natural-products?Itemid=437</loc>
<lastmod>2018-07-24T22:58:58Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/142-guidelines-central/guidelines-traditional/1530-malaysian-variation-guideline-for-natural-traditional-medicine-homeopathy-and-health-supplement-product-2016?Itemid=437</loc>
<lastmod>2018-07-23T22:56:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1603-glossary-for-cosmetic-guideline?Itemid=437</loc>
<lastmod>2018-09-12T23:02:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1602-9-halal?Itemid=437</loc>
<lastmod>2018-09-12T22:53:12Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1601-8-certificate-of-free-sale?Itemid=437</loc>
<lastmod>2018-09-12T22:52:23Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1600-7-notification-exemption?Itemid=437</loc>
<lastmod>2018-09-12T22:51:40Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1599-6-notification-withdrawal?Itemid=437</loc>
<lastmod>2018-09-12T22:44:11Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1598-5-regulatory-action?Itemid=437</loc>
<lastmod>2018-09-12T22:30:22Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1597-4-post-market-surveillance-programme?Itemid=437</loc>
<lastmod>2018-09-12T22:25:24Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1596-3-0-regulatory-requirements-for-cosmetics?Itemid=437</loc>
<lastmod>2018-09-12T22:20:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/147-guidelines-central/guidelines-cosmetic/1595-2-0-cosmetic-notification?Itemid=437</loc>
<lastmod>2018-09-12T20:42:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/149-guidelines-central/guidelines-pharmacovigilance/1604-faq-adr-reporting-by-healthcare-professionals?Itemid=437</loc>
<lastmod>2018-09-18T23:58:33Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1611-dokumen-panduan-keperluan-direktif-bilangan-2-tahun-2014-dan-bilangan-2-tahun-2015?Itemid=437</loc>
<lastmod>2018-09-24T18:54:04Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1610-guidance-document-foreign-gmp-inspection-july-2018?Itemid=437</loc>
<lastmod>2018-09-24T18:54:17Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1608-licensing-manufacturer-importer-and-wholesaler?Itemid=437</loc>
<lastmod>2018-09-24T18:54:44Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1609-garis-panduan-pemeriksaan-amalan-perkilangan-baik-apb-bagi-premis-pengilang-produk-veterinar-berdaftar?Itemid=437</loc>
<lastmod>2018-09-24T18:54:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1607-cold-chain-inspection?Itemid=437</loc>
<lastmod>2018-09-24T18:55:08Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1606-good-manufacturing-practice-good-distribution-practice?Itemid=437</loc>
<lastmod>2018-09-24T18:55:26Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/150-guidelines-central/guidelines-gmp/1541-guidelines-on-good-manufacturing-practice-for-traditional-medicines-and-health-supplements?Itemid=437</loc>
<lastmod>2018-07-22T23:33:31Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/151-guidelines-central/guidelines-laboratory-quality-control/1585-9-guideline-for-the-submission-of-protocol-of-analysis-poa?Itemid=437</loc>
<lastmod>2018-09-02T17:57:37Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/151-guidelines-central/guidelines-laboratory-quality-control/1584-10-guideline-for-the-submission-of-analytical-method-validation-amv-documents?Itemid=437</loc>
<lastmod>2018-09-02T17:31:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/152-guidelines-central/guidelines-active-pharmaceutical-ingredient-api/1519-api-administrative-procedure-quest3?Itemid=437</loc>
<lastmod>2018-07-18T19:23:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/152-guidelines-central/guidelines-active-pharmaceutical-ingredient-api/1540-regulatory-control-of-active-pharmaceutical-ingredients?Itemid=437</loc>
<lastmod>2018-07-22T23:21:43Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1586-appendix-6-guideline-on-regulatory-control-of-active-pharmaceutical-ingredients-apis?Itemid=437</loc>
<lastmod>2018-09-02T19:23:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1583-glossary-guidelines?Itemid=437</loc>
<lastmod>2018-08-30T00:28:50Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1578-appendix-13-supporting-documents-required-for-change-of-manufacturing-site-cos-application?Itemid=437</loc>
<lastmod>2018-08-29T19:51:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1570-registration-of-product-for-export-only-feo?Itemid=437</loc>
<lastmod>2018-08-29T19:52:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1577-appendix-12-conditions-and-supporting-documents-required-for-an-application-of-variation?Itemid=437</loc>
<lastmod>2018-08-29T19:49:54Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1576-appendix-10-guideline-on-patient-dispensing-pack-for-pharmaceutical-products-in-malaysia?Itemid=437</loc>
<lastmod>2018-08-29T19:48:29Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1575-appendix-9-labelling-requirements?Itemid=437</loc>
<lastmod>2018-08-29T19:46:06Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1573-appendix-14-guidelines-on-safety-data-requirements-for-complementary-medicine-products?Itemid=437</loc>
<lastmod>2018-08-29T17:13:32Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1574-appendix-8-list-of-permitted-prohibited-and-restricted-substances?Itemid=437</loc>
<lastmod>2018-08-29T19:42:09Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/194-guidelines-central/guidelines-others/1572-appendix-7-special-conditions-for-registration-for-a-particular-product-or-group-of-products?Itemid=437</loc>
<lastmod>2018-08-29T00:28:51Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/clinical-trial/clinical-trial-application-forms/1553-pkpb-300-276-inspection-application-for-phase-i-unit-accreditation-programme</loc>
<lastmod>2018-07-24T17:32:27Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/191-submission/1582-section-e-supplementary-documentation-and-particulars-of-product-owner-manufacturer-importer-and-other-manufacturer?Itemid=437</loc>
<lastmod>2018-09-02T17:58:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/191-submission/1581-section-d-label-mock-up-for-immediate-container-outer-carton-and-proposed-package-insert-pil?Itemid=437</loc>
<lastmod>2018-08-29T23:47:42Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/191-submission/1580-section-c-particular-of-packing?Itemid=437</loc>
<lastmod>2018-08-29T23:19:53Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/191-submission/1579-section-b-product-formula?Itemid=437</loc>
<lastmod>2018-08-29T23:06:30Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/192-submission/product-validation-generic/1569-product-validation-pv5-pv18-other-information?Itemid=437</loc>
<lastmod>2018-08-29T19:54:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/192-submission/product-validation-generic/1568-product-validation-4-1-4-5-excipients?Itemid=437</loc>
<lastmod>2018-08-29T20:07:07Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/192-submission/product-validation-generic/1567-product-validation-3-1-3-8-active-ingredients?Itemid=437</loc>
<lastmod>2018-08-29T19:58:46Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/192-submission/product-validation-generic/1565-product-validation-2-1-2-6-dosage-form?Itemid=437</loc>
<lastmod>2018-08-26T23:44:03Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
<url>
<loc>http://www.npra.gov.my/index.php/component/content/article/193-submission/section-a-generic/1571-a4-product-description?Itemid=437</loc>
<lastmod>2018-08-28T23:28:49Z</lastmod>
<changefreq>daily</changefreq>
<priority>0.5</priority>
</url>
</urlset>